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Acute injury of major epithelial organ systems (kidney, liver, lung, etc.) is 
collectively a principal cause of death worldwide. Regenerative medicine promises to 
meet these human health challenges by harnessing intrinsic cellular processes to repair or 
replace damaged tissues. 
Epithelial morphogenesis is a hard-wired, multicellular differentiation program 
that dynamically integrates microenvironmental cues to coordinate cell fate processes 
including adhesion, migration, proliferation, and polarization. Thus, epithelial 
morphogenesis is an instructive mode of tissue assembly, maintenance, and repair. Three-
dimensional epithelial cell cultures in natural basement membrane (BM) extracts produce 
hollow, spherical cyst structures and have indicated that the BM provides the critical cell 
adhesion ligands to facilitate cell survival, stimulate proliferation, and promote 
polarization and lumen formation. However, the utility of natural BMs for detailed 
studies is generally limited by lot-to-lot variations, uncontrolled cell adhesive 
interactions, or growth factor contamination. 
The goal of this thesis was to engineer bioartificial extracellular matrices (ECM) 
that would support and modulate epithelial cyst morphogenesis. We have engineered 
hydrogels, based on a multi-arm maleimide-terminated poly (ethylene glycol) (PEG-
4MAL), that present cell adhesive molecules and enzymatic degradation substrates and 
promote polarized epithelial cyst differentiation in vitro. 
To investigate the influence of matrix physical and biochemical signals on cyst 
morphogenesis, we independently varied the polymer weight percentage (wt%), the 
density of a cell adhesion ligand (RGD), and crosslink degradation rates of the hydrogels. 
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Then, we evaluated functional outcomes including Madin-Darby canine kidney (MDCK 
II) epithelial cell survival, proliferation, cyst polarization, and lumen formation. We 
found that cell proliferation, but not cell survival, was sensitive to the polymer wt%, 
which is related to elastic modulus and crosslink density. This result defined a working 
range of PEG-4MAL concentration (3.5% - 4.5%) that promotes robust proliferation. 
Analysis of mature cysts indicated that 4.0% and 4.5% gels produced cysts resembling 
those typically grown in type I collagen gels while 3.5% gels produced cysts with higher 
incidence of inverted polarity and multiple lumens. Perturbation of matrix degradability 
using a slow-degrading crosslink peptide or matrix metalloproteinase inhibitors showed 
that the rate of matrix degradation exerts major influence on cyst growth in PEG-4MAL 
gels. We employed 4.0% PEG-4MAL hydrogels with RGD ligand density ranging over 0 
– 2000 uM to discover that (1) lumen formation was eliminated in the absence of RGD, 
(2) extent of lumen formation increased with increasing RGD concentration, and (3) cyst 
polarity was inverted below a threshold of integrin binding to RGD. Together, these 
results show that the biochemical and physical properties of the matrix, particularly 
integrin binding and matrix degradability, effectively modulate establishment of apico-
basal polarity and lumen phenotypes in MDCK II epithelial cyst structures. Furthermore, 
these studies validate PEG-4MAL hydrogels as a powerful culture platform to enable 
detailed investigation of matrix-directed modulation of epithelial morphogenesis.
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Epithelial morphogenesis is an instructive mode of tissue assembly, maintenance, 
and repair. Three-dimensional cultures in natural basement membrane (BM) extracts 
produce spherical cyst-like epithelial structures and have indicated that the BM provides 
the critical cell adhesion ligands that facilitate cell survival, stimulate proliferation, and 
promote polarization and lumen formation. However, the utility of natural BMs for 
detailed studies is generally limited by lot-to-lot variations, uncontrolled cell adhesive 
interactions, or growth factor contamination. The objective of this project was to engineer 
bioartificial matrices to support epithelial morphogenesis. Our hypothesis was that 
protease-degradable, synthetic hydrogels optimized to present integrin-targeting cell 
adhesive motifs would support robust cyst differentiation in a manner similar to that 
observed in natural BM. The significance of this work is the development of synthetic 
microenvironments that modulate epithelial morphogenesis by controlling cell-matrix 
interactions. Toward this goal, we pursued the following specific aims: 
 
Specific Aim 1:  Quantitate the influence of PEG-4MAL polymer weight percentage 
on cyst morphogenesis in bioartificial hydrogels. 
The purpose of this aim was to characterize the physical properties of synthetic 
matrices that support epithelial morphogenesis. Multi-arm poly (ethylene glycol)-
maleimide (PEG-4MAL) macromers were functionalized via a Michael-type reaction 
with adhesive peptides and crosslinked with peptides containing matrix metalloproteinase 
2 
sensitive sequences in the presence of Madin-Darby canine kidney (MDCK II) epithelial 
cells. 
PEG-4MAL-based hydrogel elastic moduli vary linearly with PEG-4MAL weight 
percentage over the range of 4.0% and 10% (w/v). Notably, gels fabricated at 4.0% 
exhibit elastic moduli that resembles type I collagen gels [1]. We show here that these 
engineered microenvironments permit high MDCK II cell viability and promote robust 
cyst morphogenesis over 10 days in a manner similar to that observed in type 1 collagen 
gels. We adapted immunofluorescence protocols and employed confocal microscopy to 
visualize lumen formation and markers of apico-basal polarity. Our results define a PEG-
4MAL weight percentage regime that promotes robust polarized cyst morphogenesis and 
demonstrate modulation of apico-basal polarity and lumen phenotypes via adjustment of 
matrix degradability. 
 
Specific Aim 2:  Quantitate the influence of adhesive ligand density on cyst 
morphogenesis in bioartificial hydrogels.  
The purpose of this aim was to characterize the biochemical properties of synthetic 
matrices that support epithelial morphogenesis. PEG-4MAL-based hydrogels exploit a 
highly-efficient maleimide-thiol Michael addition reaction that ensures rapid and 
complete incorporation of adhesive ligand added to the hydrogel precursor solution [1]. 
Thus, adhesive ligands can be incorporated with high precision. We titrated ECM-derived 
adhesive ligand arginine-glycine-aspartic acid (RGD) over the range of 0 μM to 2000 μM 
in PEG-4MAL gels and evaluated cyst morphogenesis on the bases of cyst size, lumen 
phenotype, and apico-basal polarity. Our results indicate that MDCK II cyst 
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morphogenesis is highly-sensitive to incorporated RGD concentration. We found that (1) 
lumen formation was eliminated in the absence of RGD, (2) extent of lumen formation 
increased with increasing RGD concentration, and (3) cyst polarity was inverted below a 
threshold of integrin binding to RGD. 
 
Project Significance 
Acute injuries of major epithelial organ systems (kidney, liver, lung, etc.) are 
collectively a principal cause of death worldwide [2-5]. Several organs, including the 
kidney, lung, intestine and liver, can recover from acute injury, provided that the host 
survives the initial trauma. For instance, in kidney regeneration, partially-denuded 
epithelial interfaces are repopulated by surviving epithelial cells that secrete a specialized 
matrix, transiently differentiate to a mesenchymal phenotype, and proliferate [5-9]. 
However, several debilitating diseases, including idiopathic pulmonary fibrosis (lung), 
Crohn’s disease (intestine), and kidney fibrosis, involve permanent differentiation of 
epithelial cells to a fibrotic mesenchymal phenotype and ultimate loss of organ function 
[2, 10, 11]. 
Regenerative medicine promises to meet human health challenges by harnessing 
intrinsic cellular processes to repair or replace damaged tissues. Epithelial morphogenesis 
is a hard-wired, multicellular differentiation program that dynamically integrates 
microenvironmental cues to coordinate cell fate processes including adhesion, migration, 
proliferation, and polarization. Thus, it is an instructive mode of tissue assembly, 
maintenance, and repair. Learning how to modulate epithelial morphogenesis to control 
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cell proliferation, alter differentiation responses, and maintain cell polarity after acute 
injury could remarkably improve human health [5]. 
A potential strategy for controlling cell behavior in a multicellular context 
involves rationally-designed, ECM-mimetic biomaterials. Synthetic ECM analogues offer 
tunable elastic properties, controlled integration of cell adhesion ligands, and degradation 
by cell-secreted enzymes, all with minimal immunogenicity in vivo [12]. We have 
employed PEG-based hydrogels that controllably integrate cell adhesion ligands and 
protease-degradable crosslinks to effectively modulate epithelial cyst polarization and 
lumen formation. Thus, bioartificial matrices stand as an experimental and therapeutic 
platform offering remarkable control of the physical and biological properties of the 
microenvironment for studies of tissue morphogenesis. This work aims to marry the 
biology of the native epithelial tissue microenvironment with versatile synthetic 
biomaterials and may expose therapeutic strategies for epithelial organ regeneration. 
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Epithelial structure and function 
In metazoans, from Caenorhabditis elegans to Homo sapiens, body compartments 
are separated for localization of critical organ functions, for protection from the outside 
world, and for establishment of passageways that transport fluids and other cargo [5, 13, 
14]. The barrier between compartments is called an epithelium. Epithelia are contiguous 
sheets of cells that actively regulate movement of fluids and solutes between 
compartments. The skin and the lining of the gastrointestinal tract typify epithelial sheets. 
In glandular organs, epithelia exist in tubular forms and may feature branching 
morphology that terminates in hollow, spheroid structures surrounding a central lumen. 
Spherical epithelial monolayers are called acini, alveoli, follicles, or cysts in specific 
tissue contexts [14]. Epithelial cell sheets are polarized, in that each cell maintains three 
membrane surface types: (1) lateral cell-cell adhesion with neighboring cells; (2) a basal 
surface that adheres to underlying extracellular matrix (ECM); and (3) a free, apical 
surface that might border a lumen. In general, the lateral and basal membrane domains 
are continuous and are therefore called “basolateral” (Figure 2.1). Lateral cell-cell 
adhesion is mediated by cytoskeleton-linked transmembrane proteins and tight junction 
complexes and is critical to barrier functions. A specialized ECM called basement 
membrane is secreted and assembled by epithelial cells, and this provides critical survival 
and morphogenetic signals through cell surface receptors that also provide anchorage. In 
glandular epithelia, the lumen-facing apical surface might be characterized by microvilli 
for absorption or by cilia for movement of secretions.  
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Figure 2.1. Confocal immunofluorescence image of polarized Madin-Darby Canine 
Kidney (MDCK) epithelial cell cyst grown in protease-degradable synthetic hydrogel 
matrix with cell adhesive peptides. Green = β-catenin, red = f-actin, blue = nuclear DNA. 
 
Cell-cell adhesion and polarity 
Cell-cell adhesion is a critical aspect of the sheet-like character and barrier 
functions of epithelia. Several proteins are involved in the variety of subcellular 
structures that maintain cohesiveness in cellular sheets. These structures provide physical 
anchoring between cells, link to the actin cytoskeleton, and modulate signaling pathways 
that regulate gene expression [15-18]. Furthermore, the asymmetric cellular localization 
and intramembrane diffusion limiting functions of particular cell-cell adhesion structures 
is critical to epithelial polarity [19]. 
Tight junctions (TJs) are located close to the apical surface of an epithelium and 
serve as tight seals between cells such that the cell layer is selectively permeable barrier 
to diffusion [18, 19]. Adherens junctions (AJs), located basally versus TJs, initiate and 
maintain the physical attachment between neighboring epithelial cells. On the molecular 
level, the AJ is made up of homotypically-interacting E-cadherin molecules [15]. 






basal surface versus TJs and AJs, desmosomes are distinguished by transduction of 
intermediate filament interaction across the cell membrane [20].  
TJs are particularly versatile in that they mark the boundary between the apical 
and basolateral membrane domains and serve as a barrier to prevent diffusion of 
macromolecules between the apical and basolateral domains. Additionally, TJs are multi-
protein signaling complexes that play critical roles in cell polarity, proliferation, and 
differentiation [19, 21]. Structurally, the TJ complex is made of transmembrane proteins 
and peripheral membrane proteins that function as scaffolding proteins to link the TJ to 
the actin cytoskeleton and signaling molecules. The transmembrane protein group 
includes occludins, claudins, and junctional adhesion molecules (JAMs). These proteins 
regulate flow of fluids and ions through the gap between cells between cells while 
preventing passage of large molecules. The peripheral membrane proteins include ZO-1 
and Rab13 and facilitate organization of transmembrane proteins, allow transmembrane 
protein interaction with the cytoskeleton, and initiate cell signaling [18]. 
Given their apical localization relative the cell layer, TJs essentially define apico-
basal polarity in epithelia. In a mature, polarized epithelium, the apical plasma membrane 
domain interfaces a free surface (like a fluid-filled lumen). Compositionally, the apical 
plasma membrane is characterized by phosphatidylinositol -4,5-bisphosphate (PIP2), 
podocalyxin, annexin-2, and a dense f-actin meshwork. Morphologically, the apical 
plasma membrane is often marked by microvilli and cilia. In contrast, the basolateral 
membrane domain is enriched in β1 integrin, phosphatidylinositol-3,4,5-triphosphate 
(PIP3), and phosphoinositide 3-kinase (PI3K), the kinase that converts PIP2 to PIP3 [5]. 
The system by which intracellular trafficking machinery target newly synthesized 
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membrane components to their designated location is complex and regulated by a variety 
of pathways [22-24]. Notably, the transition between apical and basolateral membranes is 
marked sharply by the TJ, as the structure bars intramembrane diffusion. The TJ also 
dictates apico-basal polarity by specific intermolecular interactions. As will be discussed 
later, orientation of polarity in a developing epithelium is followed by generation of 




The ECM is the non-cellular component of tissues that provides mechanical 
support while sequestering and presenting growth and differentiation factors, as well as 
adhesive ligands, which are essential for survival, proliferation, migration, and nutrient 
storage [28]. It is a hydrated meshwork of glycoproteins and proteoglycans that has nano-
, micro-, and macro-scale organization [29]. Macro-scale features of ECM include folds, 
bends, invaginations, and protrusions formed by patterned matrix secretion, matrix 
swelling, and cell contractility [13]. The major components of the ECM are the large, 
insoluble macromolecules collagen, laminin (LM), fibronectin (FN), and proteoglycans, 
including hyaluronan, organized in fibrillar or isotropic networks with nano-scale order. 
The ECM is dynamic in that its secretion, assembly, and degradation by cells is regulated 
by developmental stage and is altered in disease and regeneration [13, 30, 31]. 
The basement membrane (BM) is a 20 – 100 nm thick layer of specialized ECM 
that underlies epithelia and provides ligands for anchorage and signaling via cell surface 
receptors. Furthermore, the BM physically isolates epithelia (as well as blood vessels, 
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muscle, fat, and peripheral nerve cells) from the surrounding connective tissue. From the 
early steps of embryogenesis, the basement membrane is critical for tissue development 
[32]. The BM is secreted and assembled by epithelial cells and is rich in type IV collagen 
and various LM isoforms [13, 32-35]. These two major components form independent, 
weakly interactive networks that are interconnected by minor BM components, namely 
nidogens [32, 33, 36-38]. Type IV collagen is thought to provide mechanical stability 
[33], whereas both LM and collagen provide cell adhesive motifs bound by integrins and 
dystroglycan [30, 33]. Much of what is known about BM composition, assembly, and 
function is derived from studies of the Englebreth-Holm-Swarm (EHS) mouse tumor 
basement membrane. The EHS tumor produces copious amounts of matrix from which 
individual macromolecular components can be purified [39-42]. 
As the collagen IV scaffold of the BM seems to depend on initial secretion and 
assembly of LM, it has been concluded that LM is the centerpiece of the BM [39]. The 
LM molecule is a large glycoprotein consisting of three polypeptide chains associated in 
a cross-shaped coiled coil. Each LM macromolecule is a heterotrimer containing one 
each of α, β, and γ chains. Five LM α, four β, and three γ genes have been identified in 
mammals, with two forms of α3 owing to alternative splicing. LM subunits are secreted 
in 15 combinations that are known to be stable (Figure 2.2). LM-332, for instance, is 
composed of α3, β3, and γ2 chains. There are three short arms in the cruciform 
macromolecule that correspond to N-terminal ends of each constituent chain while the 
long arm is the coiled-coil region made from the C-terminal ends of all three chains. At 
each terminus, several bioactive domains are found. These include cell surface receptor 
recognition motifs, enzyme degradation sites, homo- and heterotypic LM chain 
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interaction sites, and domains where LM binds other ECM molecules [43, 44]. 
Importantly, LM-111 contains an Arg-Gly-Asp (RGD) amino acid motif and mediates 
cell adhesion via cell surface integrin receptors [45].  
 
Figure 2.2. The human or mouse laminin (LM) heterotrimers. From [43]. 
 
While it is known that LM is deposited into the basement membrane by epithelial 
cells, its assembly into a network is not well understood [34]. Laminins are secreted as 
intact heterotrimers and some are then proteolytically processed in a way that might 
affect receptor binding [46]. It initially appeared that self-assembly of laminins into 
polymers and co-polymers in vitro requires that all trimer arms be full-length [38]. 
However, surface plasmon resonance has been used to observe interactions of LM-332, 
having a truncated β chain, with itself and with LM-511 that suggest that truncated-arm 
laminins may be involved in provisional matrices that are then stabilized by addition of 
full-length laminins [31, 47]. Nevertheless, pericellular polymerization of laminins occurs 
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as the trimers are bound to cell surface receptors [48, 49]. The α3β1 integrin modulates 
LM-332 deposition in vitro and α6β4 might also be involved [50-52]. Integrins are 
thought to regulate LM deposition via signaling by Rho GTPases including Rac1. After 
integrin binding activates Rac1 and inhibits rhoA, Rac1 causes integrins to organize 
secreted LM at the cell periphery [53-55]. The details concerning how integrins regulate 
LM deposition via Rac1 remain unclear but one model is that Rac1-induced actin 
reorganization causes integrins to move about on the membrane such that they alter the 
conformation of freshly secreted LM-332. A similar mechanism is observed in FN 
secretion and assembly [34, 56, 57]. 
Laminins have been shown to have profound impact on epithelial tissue 
morphogenesis in vivo, having roles in cell survival and polarization among others. The 
expression patterns of the various LM isoforms is tissue-specific and is dependent of 
developmental phase and disease state [44]. LM-111 was the first to be discovered and is 
also the most extensively studied of all the isoforms [30, 58]. Furthermore, LM-111 is 
perhaps the most widely distributed of the laminins and it has been shown to have critical 
roles in embryonic BM assembly [30, 32]. In mouse embryonic kidney development, 
LM-111 and LM-511 are found in the basement membrane surrounding the ureteric bud, 
the epithelial outgrowth that invades the metanephric mesenchyme and causes it to 
condense into an epithelium via a mesenchymal-epithelial transition (MET). 
Morphogenetic transitions of this epithelium give rise to the nephron, the functional unit 
of the kidney [44]. In ex vivo cultures of embryonic kidney, antibodies against the LM α1 
chain block the nephrogenic MET [59]. Also, embryos lacking the gene encoding LM α5 
chain show disrupted ureteric bud branching [60]. Whereas expression of LM-332 is 
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sparse in the healthy kidney, its expression is widespread during regeneration following 
ischemic renal injury and in polycystic kidney disease [31, 61]. In vitro studies with 
MDCK cells and in vivo studies in a rat model of ischemic renal injury indicate that LM-
332 is required to stimulate cell proliferation and cell spreading in order to reconstitute an 
intact epithelium. MDCK cells synthesize and secrete LM-332 while sub-confluent, and 
spread on the provisional matrix via α6β4 and β1 integrins, and then subsequently 
degrade the matrix upon reaching confluence. In this context, polymerization of LM-511 
is thought to be responsible for polarization of the regenerated epithelium [31]. Such 
studies suggest a role for LM-332 in normal regeneration of renal tubular epithelia after 
injury and in pathological generation of renal cysts. 
 In the lung, several LM isoforms are present during embryonic 
development and in the adult tissue. The LM α1 chain is critical for branching. 
Specifically, in human embryonic lungs, LM α1 is present specifically at the tips of 
advancing branch tips and not at proximal portions. Whereas LM α1 is present only 
during pre-natal lung development, LM α5 is present throughout organogenesis and is 
thought to be involved in epithelial cell differentiation. Whether LM-332 plays a critical 
role in wound healing following lung injury, as it does in kidney, is yet to be seen [62]. 
Observations are complicated by the lethal skin disease that affects mice that lack LM α3 
[63]. Nevertheless, knockdown of LM α3 expression results in increased type I collagen 
deposition at the alveolar epithelial basement membrane, suggesting a role of LM α3 in 
inhibiting fibrosis [64]. 
 
Cell-ECM adhesion  
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Epithelial cells are anchored to the basement membrane via cell surface receptors 
that bind specific components of the basement membrane. These receptors include 
integrins, dystroglycans, syndecans, and less specifically classified receptors including 
the 67 kDa and 110 kDa LM receptors. The family of integrins represents the best 
understood class.  
Integrins are transmembrane glycoproteins that link the cytoskeleton to the ECM 
with wide-ranging consequences for cell behavior in all metazoans [65]. Each integrin is 
a heterodimer, consisting of α and β chains. Of the 24 known integrin subunit 
combinations in mammals, epithelial cells typically express β1, β3, or β4 subunits paired 
with any of a number or α subunits, thus allowing interaction with ECM components FN, 
LM, and collagens [66]. Most of the β1 subunit-containing heterodimers (α1β1, α2β1, α6β1, 
and α3β1) are receptors for collagen and LM. Meanwhile, α5β1 and αVβ3 are receptors for 
the RGD peptide of fibronectin and other adhesive proteins. Finally, α6β4 is an epithelial-
specific integrin that binds LM [65](Figure 2.3). Integrins function not only to provide 
anchorage but also to transduce signals bi-directionally [33, 50, 65, 67]. Upon binding 
extracellular ligand, integrin outside-in signaling involves assembly of multimeric 
signaling complexes at the short cytoplasmic tails of the heterodimer. These complexes 
initiate various signaling cascades that regulate survival, proliferation, and differentiation 
[65]. Inside-out signaling may involve association of actin-binding proteins with the 
cytoplasmic tails of bound integrins. Cell contractility then causes assembly or 
deformation of ECM networks [33, 51, 65]. 
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Figure 2.3. The family of integrin receptors. Laminin, collagen, and RGD motif 
binding integrins are grouped. From [65]. 
 
Epithelial morphogenesis 
Epithelial morphogenesis refers to the dynamic integration of environmental 
stimuli in a hardwired genetic program that produces and maintains epithelial tissue 
structures [14]. In vivo development of epithelial tissues involves coordination of cell fate 
processes including proliferation, migration, cell death, and differentiation. Thus, 
epithelial morphogenesis is a valuable model that provides insights into many aspects of 
physiology that are relevant for tissue regeneration. Historically, epithelial 
morphogenesis has been observed ex vivo with embryonic kidney explants and in the 
morphological transitions of the adult mammary gland [68-73]. In vitro, two-dimensional 
cultures of epithelial cells on permeable filters has given way to three-dimensional 
cultures in natural or synthetic matrices and, together, have provided fruitful models for 
investigation [5]. 
 
In vitro models: Cyst morphogenesis 
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Monolayers of cultured epithelial cells were the first in vitro models of epithelial 
tissues. The Madin-Darby canine kidney (MDCK) cell line was derived from renal 
collecting tubules of a Cocker-Spaniel kidney and has been used extensively in research 
[74, 75], as have human mammary epithelial cell lines (e.g., MCF-10A) [76], and human 
intestine-derived cell lines (e.g., Caco-2) [77, 78]. Fluorescently-labeled antibodies and 
confocal microscopy have been used to visualize apically-, basally-, and laterally-
segregated membrane proteins and cell surface receptors. As many proteins are targeted 
to both the basal and lateral membranes, the two surfaces are captured together in the 
term “basolateral” [14]. Polarized MDCK epithelial sheets feature ductal characteristics 
including solitary cilia, apical microvilli and tight junctions. Microvilli increase surface 
area for absorptive function. Tight junction complexes mark the apical-lateral border and 
serve to limit paracellular fluid transport across the monolayer. Early studies revealed 
that apico-basal polarity involves active segregation of membrane-associated proteins to 
distinct domains using intracellular trafficking machinery [23, 25]. 
Induction of epithelial cell polarity has been found to depend on both cell-cell and 
cell-ECM adhesion [14]. Three-dimensional (3D) cultures of MDCK and other epithelial 
cells in extracts of natural basement membrane trigger robust cyst development. Type I 
collagen gels and the complete EHS basement membrane extract, known as Matrigel
TM
, 
have been used most extensively [14, 79-86]. These polarized cysts represent near-
physiological epithelial tissue rudiments. Introduction of hepatocyte growth factor (HGF) 
to these cultures elicits epithelial-mesenchymal transitions (EMTs) that resemble 
tubulogenesis in vivo [87-89]. These 3D cultures have allowed perturbation of cellular 
machinery and have yielded tremendous insight into the mechanisms by which basement 
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membrane attachment-associated signals orient polarity and drive lumen formation to 
establish and maintain epithelial tissue architecture [14]. 
Type I collagen gels have been used extensively as substrates for 2D cell culture 
studies and as matrices for 3D cultures [90-92](Figure 2.4). For epithelial cells, collagen 
gels were initially used to observe histotypic growth and reorganization of mouse 
mammary and pig thyroid cells embedded within [81, 82, 84, 85, 93, 94]. The first 
reported 3D cultures of MDCK cells involved a fibrin clot in which MDCK formed 
polarized cysts with lumens [79]. When MDCK cells were grown in a monolayer on 
collagen gel and then overlaid with yet more collagen gel, small cysts formed via cell 
aggregation [83]. However when single MDCK cells were cultured dispersed in collagen 
gel, polarized cysts formed clonally with a single cell giving rise to each cyst [80]. The 
same group demonstrated that MDCK cysts could be extracted from collagen gels using 
collagenase and subsequently resuspended in collagen or dissociated  and plated to form 
monolayers [80]. The flexibility of the collagen gel culture system and the resilience of 
MDCK cysts facilitated other studies that investigated reversal of cyst polarity upon 
change of extracellular environment. Whereas MDCK cysts cultured in collagen gels 
polarize such that the apical surface borders the lumen and the basal surface interfaces the 
collagen matrix, cysts formed in suspension culture show opposite polarization. In 
suspension-grown cysts, apical membrane proteins localize to the exterior of the cyst 
while basement membrane proteins are secreted into the lumen. Embedment of these 
suspension-grown cysts in collagen simultaneously provides an ECM interface and 
eliminates the free exterior surface. The result is reversal of polarity, as the cysts degrade 
the luminal basement membrane [93, 95-97] [55]. 
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Figure 2.4. Epithelial cell growth characteristics in vitro. a, Cell division, apoptosis, and 
shape change over a period of several days in embedded culture often leads to a stable, 
lumen-containing cyst formed by a single layer of ECs. b, ECs plated on a layer of 
collagen (surface culture) typically generate a stable, uniform monolayer. c, Inverted 
cysts (cell polarity relative to that in a is inverted) form in suspension culture, with matrix 
deposited on the inside of the cyst. d, Lumens are frequently formed in collagen overlay 
experiments. From [98]. 
 
In 3D cultures, it has been shown that integrins have critical roles in survival, 
establishment of polarity, and lumen formation. MDCK bind to collagen via α2β1 integrin 
[99]. Inhibition of α2β1 integrin-mediated adhesion to type I collagen gels reduces cyst 
formation, increases apoptosis, and blocks HGF-induced tubulogenesis [100]. 
Furthermore, apical surfaces of MDCK cysts have a small pool of inactive α2β1 integrins 
that are activated when overlaid with collagen and mediate signaling that results in 
polarity reversal [99, 101-103]. 
During the course of cyst development, MDCK cells in type I collagen secrete 
and assemble a basement membrane of LM and type IV collagen (Coll IV) with a layer of 
fibronectin, a ligand for integrin α5β1. Ablation of the fibronectin matrix with siRNA 
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resulted in increased apoptosis [104]. Notably, as Matrigel
TM
 is a basement membrane 
derived from a mouse tumor, it is a pre-assembled matrix consisting primarily of LM and 
type I collagen, and myriad other components in smaller quantities [105]. Thus, MDCK 
cells embedded in Matrigel
TM
 encounter immediate presentation of α3β1- (LM) and 
α6β4-(Coll IV) integrin binding ligands. As will be discussed later, the quality and timing 
of basement membrane assembly, and subsequent integrin binding, are critical for 
establishment of epithelial cyst polarity. 
Cells derived from intestine, mammary gland, and lung, also form hollow, 
polarized, cyst-like structures when embedded in natural ECM extracts, with some 
mechanistic variety [35, 106-109]. Normal mammary epithelial cells (MECs) form acini, 
single layers of polarized, growth-arrested cells surrounding a hollow lumen when grown 
in Matrigel
TM
 [76]. Induction of oncogenes in these cultures have elucidated important 
roles for ECM properties in mammary tumor metastasis [110, 111]. Importantly, primary 
MECs from β1 integrin knockout mice were used to show that β1 integrin binding in the 
mammary gland triggers alignment of microtubules to facilitate cell membrane 
asymmetry and polarized localization of the golgi apparatus [24]. 
Establishment of polarity 
It is critical that the polarity of each constituent cell is aligned with the overall 
tissue structure in order for the tissue to function [54]. Indeed, in the developing kidney, 
cells surrounding the ureteric bud aggregate and polarize before forming a lumen [112]. 
Mostov, Matlin, Nelson and many others have investigated the mechanisms by which 
integrin signaling aligns the axis of epithelial polarity to the overall tissue architecture [5, 
25, 66, 113]. 
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Today, epithelial tissue polarization is thought to occur in two steps: (1) an axis of 
polarity is selected; and (2) molecular asymmetry is generated along that axis [25]. 
 
(1) Selection of an axis of polarity 
Beginning with the observation that classical Rho family GTPases (RhoA, rac1, 
Cdc42) play roles in polarization, Mostov and colleagues investigated the role of cell-
ECM interactions in establishment of an axis of polarity. Rac1 along with other Rho 
family proteins (RhoA and Cdc42) are known to propagate polarization signals by 
remodeling the actin cytoskeleton near the cell membrane. Whereas mutant Rac1 does 
not alter polarity in MDCK monolayers, expression of dominant negative Rac1 causes 
inverted cyst polarity in 3D culture [16, 54]. Furthermore, mis-assembly of the 
pericellular LM basement membrane was observed. Exogenous LM was recruited to the 
cyst surface and rescued proper cyst polarity. Subsequent work in the same group 
identified the necessity of β1 integrin in LM assembly and in signaling to allow polarized 
cyst morphogenesis [53]. Thus, Rac1 and LM comprise an autocrine pathway through β1 
integrin that orients the apical pole in cyst morphogenesis. The proposed mechanism is 
that intracellular Rac1 controls extracellular LM assembly via integrin-cytoskeleton 
interactions. Then, the extracellular LM acts on the cells via β1 integrins to direct 
orientation of apical pole [54]. 
 
(2) Generation of membrane asymmetry 
Mostov and colleagues used siRNAs and introduction of dominant negative 
proteins to alter expression and function, respectively, of phosphatase and tensin 
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homolog (PTEN), annexin 2 (Anx2), Cdc42, and atypical protein kinase C (aPKC), all 
proteins thought to be critical to MDCK apical (AP) plasma membrane (PM) and lumen 
formation [27, 114-118].  Additionally, proteins were added exogenously to the PM to 
investigate effects. From their findings that loss of function of any one of the 
aforementioned proteins prevents normal AP/PM and lumen formation, a mechanism that 
links MDCK epithelial cell AP/PM development to lumen formation was proposed. 
Initially, the phosphoinositides PIP2 and PIP3 are distributed throughout the cell 
membrane. Once tight junctions (TJs) are formed, PTEN, a phosphatase, is targeted to the 
TJs where it antagonizes the behavior of PI3K (the kinase that phosphorylates PIP2 to 
PIP3) and converts PIP3 to PIP2. The result is enrichment of PIP2 near the TJs. PIP2 is 
bound strongly by Anx2, a protein involved in apical transport that recruits Cdc42 to the 
now established apical domain. There, Cdc42 binds the Par6/aPKC polarity complex 
[27]. Lumen formation is believed to be tied to this process by the membrane protein 
trafficking machinery [119]. Specifically, apical membrane proteins are embedded in 
intracellular vacuoles called vacuolar apical compartments (VACs) that fuse with the 
designated region of cell-cell contact and exocytose fluid that makes up the lumen [120-
122]. Depletion of Cdc42 causes intracellular accumulation of aPKC. Thus, VACs are 
never targeted to the cell membrane and, instead, fuse in the cytoplasm, resulting in cysts 
with multiple lumens. [27]. 
Thus, two pathways are at work in polarization of MDCK cysts. A Rac1–β1 integrin–LM 
pathway determines the axis of polarity while a PTEN–PIP2–Anx2–Cdc42 pathway 
defines the AP surface and drives lumen formation. Although the connection is unclear, 
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the two pathways may be linked by Rac1 control of Par3/Par6/aPKC complex at TJs 
where PTEN is targeted [27]. 
 
Lumen formation 
The hollowing mechanism of lumen formation described above is one of many 
observed in metazoans. Others include wrapping, budding, and cavitation [119]. Both 
hollowing and cavitation can be observed in MDCK cyst and tubule development in 3D 
cultures [89, 123]. Whereas hollowing involves exocytosis of vacuolar fluid to establish a 
lumen without cell loss, cavitation involves matrix-detachment associated apoptosis 
(anoikis) at the center of a solid cell cluster [119, 124]. Recent work by Mostov and 
colleagues has illustrated the relationship between rate of polarization and mode of lumen 
clearance. MDCK cells were cultured embedded in type I collagen or in Matrigel
TM
, the 
type IV collagen- and LM-rich extract of  EHS basement membrane widely used in 3D 
culture assays [40, 76]. In Matrigel
TM
, MDCK cells rapidly formed polarized clusters and 
exhibit lumens within 24 – 48 hours without cell death. Laminin, provided by Matrigel
TM
, 
provides a strong polarization signal through integrin binding, as discussed earlier. In 
type I collagen gels, there was an initial, low-polarization phase (1 – 3 days) followed by 
an apoptotic phase (4 – 10 days) in which cells polarized and luminal cells were 
eliminated by apoptosis. In Matrigel
TM
 cultures, delay of polarization by blockade of 
Cdc42 induced apoptotic clearance of lumens. Thus, slow polarization necessitates 
apoptotic cavitation for lumen formation whereas rapid polarization induces a hollowing 
mode of lumen formation with reduced need for apoptosis [123]. 
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In summary, 3D cultures of epithelial cells have uncovered design principles and 
mechanistic frameworks for alignment of epithelial polarity to overall tissue architecture 
and development of lumens. Epithelial cells sense environmental cues using cell surface 
receptors and then secrete and assemble basement membrane that provides integrin-
mediated signals that establish an axis of polarity. Finally, membrane trafficking 
programs simultaneously distinguish membrane domains and establish the lumen. 
Nevertheless, there remains much to be learned about the mechanistic connections 
between extracellular ligand binding, polarization, and the various modes of lumen 
formation. The specific effects of binding particular integrins, the nature of cooperation 
between integrin and non-integrin receptors, and the specific signaling roles of minor BM 
component must be clarified. Also, the stimuli and signaling involved in the alterations of 
BM composition observed in injury and regeneration are not understood. Ultimately, a 
move from observing to modulating epithelial morphogenesis will be necessary in order 
to affect human health, particularly in acute injuries to epithelial organs. This requires 
strategies that leverage biological insights from 3D culture experiments to control 
proliferation, dictate EMTs and METs, and manipulate polarity for tissue and organ 
regeneration. 
While natural BMs inherently provide biological recognition and susceptibility to 
proteolytic remodeling, they alone are not sufficient to develop therapeutic platforms that 
dictate specific morphogenetic programs [12]. Generally, natural BM extracts are limited 
by uncontrolled presentation of cell adhesive motifs, lot-to-lot variations in composition, 
unavailability of materials matching composition of cells’ native BM, limited control of 




, even with growth factor-reduced varieties, are complicated by the presence 
of a host of growth factors including IGF-1, TGF-β, and EGF. Type I collagen, for all its 
value in 3D culture of MDCK cells, only ligates integrin α2β1, leaving the roles of other 
integrins unexplored.  
 
Synthetic matrices for epithelial morphogenesis 
A recently-advanced strategy for controlling cell behavior in a multicellular 
context involves rationally-designed, ECM-mimetic biomaterials. Synthetic ECM 
analogues offer tunable elastic properties, controlled integration of cell adhesion ligands, 
and degradation by cell-secreted enzymes, all with minimal immunogenicity in vivo. 
These bioartificial matrices are finding application as in vitro cell culture materials, 
implantable vehicles for tissue rudiments constructed ex vivo, and as implanted niches 
that induce ingrowth from surrounding tissues [12]. 
Whereas some natural ECM-derived materials are approved for therapeutic 
applications, for example fibrin glue for wound healing and collagen as tissue sealant, 
many of the priority cell biological investigations and regenerative medicine applications 
will require customized matrices with precise control over their physical and biochemical 
properties [12, 125, 126]. Of synthetic ECM-mimetics, there are several classes. Self-
assembled nano-fibrillar matrices formed in situ recapitulate a key structural feature of 
the ECM. However, few of these materials assemble under conditions that are amenable 
to cell survival. Of those, supramolecular gels of self-assembled oligomeric amphiphiles 
that incorporate biomolecular ligands have shown promise [127]. The major limitations 
of self-assembled fibrillar gels include high cost, harsh reaction conditions, weak 
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mechanical properties, and lack of control of degradation. Synthetic polymer hydrogels 
are a logical choice for biomedical applications, as hydrogel character is a key feature of 
natural ECMs. In addition to recapitulating viscoelasticity and transport properties of 
natural ECM, synthetic polymer hydrogels can be formed in situ in the presence of cells 
and even in vivo [128]. 
Poly (ethylene glycol) (PEG) hydrogels are the gold standard for cell- and tissue-
interactive synthetic biomaterials, owing to hydrophilicity that results in highly-swollen 
gels with tissue-like properties, non-fouling character that presents a “clean slate” to 
biological systems, and excellent acceptance in vivo [129]. For this reason, cell-
encapsulating PEG hydrogels that present cell adhesion ligands and protease-sensitive 
crosslinking peptides have found broad experimental applications including regulation of 
cell migration, therapeutic vascularization, and stem cell differentiation [130-136]. In 
general, PEG-based bioartificial matrices are modular systems that comprise linear or 
multi-armed PEG chains that are crosslinked into a network. To confer bioactivity, the 
PEG macromers may be functionalized with ECM-derived proteins or peptides or 
tethered growth factors. To allow cell-mediated degradation, protease-sensitive 
oligopeptides derived from ECM may be incorporated into the network, often as the 
crosslinking molecule. For cell encapsulation, the crosslinking step is conducted while 
cells are suspended in the precursor solution. 
PEG-based bioartificial matrices can be broadly classified by crosslinking 
chemistry. The two most popular approaches are photo-initiated radical polymerization 
and Michael-type addition. In radical polymerization, a photo-sensitive radical initiator is 
added to a solution of acrylate-terminated PEG macromers and activated by ultraviolet 
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(UV) light irradiation. The initiator fragments into a pair of radicals that attack the 
acrylate, converting it to a radical, and the free-radical propagation results in covalent 
bonds between acrylate groups for the duration of irradiation [137]. The result is a three-
dimensional crosslinked network. Conjugation of PEG-acrylates to adhesive peptides and 
protease-sensitive peptides prior to photo-initiation confers bioactivity to the engineered 
hydrogel. Photo-initiated crosslinking schemes are attractive in that they offer controlled 
initiation and termination of the crosslinking reaction, rapid reactions, and spatial control 
[137]. These features enable remarkable versatility and interesting experimental 
approaches. One of the most interesting features is the potential to spatially pattern 
bioactivity in 3D [138-141]. Specifically, gradients of cell adhesive ligands can be 
produced using graded irradiation via masks and other techniques [139]. Also, cell 
adhesive features can be localized with nano-scale resolution using two-photon laser-
irradiation techniques [141]. Thus, after encapsulating cells, additional adhesive ligands 
can be added into the matrix. Alternatively, crosslinks may be added or degraded during 
the course of 3D cell culture to change the structure and properties of the 
microenvironment [138, 139]. Generally, the disadvantages of free-radical polymerized 
hydrogels are use of cytotoxic UV irradiation, potentially harmful initiator reagents, and 
uncertainty about the safety of degradation products and initiator residues [137]. 
Furthermore, in therapeutic applications, photo-crosslinking in situ is limited to 
implantation sites where proper irradiation is feasible. Nevertheless, with the 
development of blue- or white-light irradiation systems paired with eosin Y 
photoinititator, free-radical polymerization remains an appealing strategy for fabrication 
of hydrogels for cell encapsulation [142]. For instance, West and colleagues recently used 
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white light and eosin Y to fabricate an enzymatically-degradable, PEG-diacrylate-based 
system with RGD to investigate the influence of microenvironment on lung cancer 
spheroid morphogenesis [143]. 
The Michael-type addition reaction is high-yield conjugation reaction between a 
nucleophile (e.g. thiol or amine) and an unsaturated alkene group (e.g. maleimide, 
acrylate, vinyl sulfone) that has been employed extensively in bioconjugate chemistry. In 
the context of fabricating PEG hydrogels, Michael-type addition with thiols offers rapid, 
efficient reactions that proceed at physiological temperature and pH without toxic 
reagents or side-products. Additionally, with tunable reaction kinetics, the rate of gelation 
can be controlled to facilitate rapid cell encapsulation without sedimentation and to allow 
direct application at an implant site. One way to conjugate PEG to peptides and proteins 
is to use N-hydroxysuccinimide esters of PEG carboxylic acids (PEG-NHS) and similar 
approaches. However, such PEGs react non-selectively with amines and thiols on the 
target protein or peptide and result in a mixture of products [144]. Notably, this is the 
general approach to prepare bio-functional PEGs for fabrication of photo-crosslinked 
PEG hydrogels [136, 143]. In contrast, the unsaturated alkene-terminated PEGs used in 
Michael-type addition react selectively, with thiols reacting at least one order of 
magnitude faster than amines [145]. Furthermore, with reduced thiols being rare in the 
extracellular milieu, the thiol Michael addition is potentially bio-orthogonal, proceeding 
without side reactions in vivo [146]. To make hydrogels with Michael-type addition, 
Hubbell and colleagues reacted a vinyl sulfone-terminated four-arm PEG (PEG-4VS) 
with bis-cysteine peptide to form a cross-linked network [147]. Functionalization of the 
PEG-4VS with adhesive peptide (e.g., GRGDSPC) and inclusion of a protease-sensitive 
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amino acid motif (e.g., GPQGIWG) in the bis-cysteine crosslinking peptide conferred 
bioactivity and cell-mediated degradation [131, 148, 149]. When primary human 
fibroblasts were encapsulated in these hydrogels, the speed and extent of migration were 
modulated by the adhesive ligand density, the amino acid sequence of the crosslinking 
peptide, and the length of the PEG arms in the PEG-4VS [130]. We adapted these 
bioartificial hydrogels as a model ECM for modulation of epithelial morphogenesis and 
showed that integration of RGD peptide or LM-111 significantly enhanced formation of 
polarized MDCK cysts with lumens [150]. 
Michael-type addition kinetics can be modulated by the type of alkene, the pKa of 
the thiol, pH of the buffer, and the concentration of base (often triethanolamine, TEA) in 
the buffer. Under a given set of conditions, the Michael reactivity of unsaturated alkenes 
is as follows: 
                                                            [1, 
144] 
In the initial studies by Hubbell and colleagues, 300 mM TEA and pH 8.0 was 
used to fabricate PEG-4VS hydrogels [130]. Such levels of TEA cause toxicity for 
sensitive cell types like thyroid follicles and human umbilical vein endothelial cells [1, 
151]. We recently demonstrated that a commercially-available, maleimide-terminated 
four-arm PEG (PEG-4MAL) enables rapid and complete functionalization and improved 
crosslinking versus PEG-4VS and acrylate-terminated PEG (PEG-4A), all with low (2 – 
4 mM) TEA at pH 7.4. With reactions that proceed to completion, as evidenced by 
consumption of free thiols, PEG-4MAL hydrogel fabrication is a stoichiometric 
combination of three modules: PEG macromer, adhesive ligand (any cysteine-containing 
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protein or peptide), and bis-cysteine crosslinking peptide [152]. We also found that high 
reaction efficiency had significant implications for hydrogel structure and allowed 
rational tuning of swelling and elastic modulus [152]. PEG-4MAL hydrogels have also 
been used in vivo for cell-demanded therapeutic growth factor release and for pancreatic 
islet transplantation and vascularization [152, 153]. Specifically, PEG-4MAL gels that 
released incorporated vascular endothelial growth factor (VEGF) and hepatocyte growth 
factor were applied directly to myocardial infarcted rat hearts and improved cardiac 
function over weeks as growth factor was released in response to cell-secreted proteases 
[153]. PEG-4MAL hydrogels functionalized with VEGF-A and RGD were used to 
encapsulate mouse pancreatic and then transplanted into diabetic mice. The recipient 
mice showed complete reversal of diabetic hyperglycemia, and exhibited improved 
weight gain, regulation of glucose challenge, and islet engraftment versus diabetic mice 
receiving injected islets, all with a smaller number of islets [152]. Thus, PEG-4MAL 
hydrogels can be engineered to maintain and structure and function of complex, 
multicellular tissue modules. In summary, bioactive hydrogels formed via Michael-type 
addition, particularly with PEG-4MAL, have clear advantages over alternative 
chemistries. These include commercially-available starting material, rapid stoichiometric 
reactions, and bio-orthogonality, all at physiological pH and temperature, without toxic 
additives. 
 With increasing emphasis on understanding tissue development processes, 
engineering cell fate, and therapeutic delivery of functional tissues, engineered ECM 
mimics like PEG-4MAL may become key platforms for fundamental investigations of 
tissue morphogenesis.  
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CHAPTER III:  INFLUENCE OF POLYMER WEIGHT PERCENTAGE ON 




Three-dimensional (3D) cell cultures in natural ECM extracts, including type I 
collagen (Coll I) , enable observation of epithelial morphogenesis, a hard-wired, 
multicellular differentiation program that integrates cell-ECM adhesion, cell 
proliferation, and ECM remodeling to achieve functionally differentiated structures like 
hollow cysts and tubules [154]. Nevertheless, critical limitations of natural ECM extracts, 
including clinical incompatibility, lot-to-lot variability and undefined presentation of cell 
adhesion motifs motivated development of a synthetic ECM platform for detailed studies. 
Here, a multi-arm poly (ethylene glycol) (PEG)-maleimide macromer (PEG-4MAL) is 
covalently functionalized with adhesive peptides and crosslinked with proteolytically-
cleavable structural peptides in the presence of epithelial cells. A highly-efficient 
Michael-addition reaction enables fabrication of hydrogel with elastic properties 
resembling natural ECMs [1]. By culturing MDCK II epithelial cells in these engineered 
PEG-4MAL matrices over a range of polymer wt%, we showed that the physical 
properties of the matrix such as elastic modulus, network crosslink density and 
degradability effectively modulate establishment of apico-basal polarity and lumen 




Organization of epithelial cells into polarized, 3D tissue structures is critical to the 
barrier, secretion, and exchange functions of organs including lung, kidney, intestine and 
salivary gland. Disruption of the 3D structure or dysregulation of the polarity in epithelial 
tissues occurs with significant morbidity and mortality [155]. When epithelial cell lines 
like MDCK are encapsulated in Coll I gels, hollow spherical monolayer structures called 
cysts form within 10 days and bear the hallmarks of epithelial polarity [92, 95, 96, 156]. 
Such 3D cultures of epithelial cells in natural ECM extracts have revealed that 
development and maintenance of intricately ordered epithelial structures (a process 
termed epithelial morphogenesis) involves coordination cell fate processes including 
adhesion, migration, differentiation, polarization, and apoptosis. Furthermore, these 
studies have exposed a powerful role of ECM in a framework of bi-directional signaling 
where cells embedded in matrix sense the adhesive signals and mechanical properties of 
the matrix while actively remodeling the matrix via proteolytic degradation and secretion 
of new matrix [24, 35, 53, 65]. Thus, 3D culture of epithelial cells in natural ECM 
extracts is a critical tool for studying development and maintenance of tissue architecture 
and their implications in organ function. 
Nevertheless, studies of epithelial morphogenesis in natural ECMs are limited by 
the uncontrolled presentation of adhesive ligands, limited control of elastic properties, 
lot-to-lot variability, and concerns over clinical use of animal-derived materials. In 
contrast, an engineered matrix that specifically and controllably presents biological 
functionalities, with tunable elastic properties, could be a useful platform for elucidating 
key influences of ECM properties in tissue morphogenesis. PEG hydrogels are the gold 
standard for cell- and tissue-interactive synthetic biomaterials, owing to hydrophilicity 
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that results in highly-swollen gels with tissue-like properties, non-fouling character that 
presents a “clean slate” to biological systems, and excellent acceptance in vivo [129]. For 
this reason, cell-encapsulating hydrogels that present cell adhesion ligands and protease-
sensitive crosslinking peptides have found broad experimental applications including 
regulation of cell migration, therapeutic vascularization, and stem cell differentiation [1, 
130-133, 136, 152]. We previously showed that PEG-based hydrogel systems could 
support MDCK cyst morphogenesis [150]. Here, we present a four-arm PEG-maleimide 
(PEG-4MAL)-based system that offers superior reaction efficiency, a wide range of 
achievable elastic properties, and cell-responsive degradation as a bioartificial matrix to 
modulate epithelial morphogenesis. By culturing MDCK II epithelial cells in these 
engineered PEG-4MAL matrices over a range of polymer weight concentrations, which 
results in variations in elastic moduli and network crosslink density, and observing apical 
polarity and lumen phenotypes in the resulting cysts, we demonstrate a versatile platform 
for modulating epithelial morphogenesis. 
 
Results 
To demonstrate the functionality and flexibility of PEG-4MAL-based hydrogels 
as an ECM analogue and 3D culture system for epithelial cyst morphogenesis studies, we 
embedded MDCK II epithelial cells in PEG-4MAL matrices and monitored cyst 




Figure 3.1. PEG-4MAL hydrogel chemistry and cell encapsulation scheme. a, 
Michael-type addition reaction. TEA, triethanolamine. b, 4-arm PEG Maleimide 
macromer. c, Sample cell-laden PEG-4MAL hydrogel. d, Cartoon of cell encapsulation 
scheme in bioactive PEG-4MAL hydrogel. First, PEG-4MAL macromers are 
functionalized with GRGDSPC adhesive ligand. Next, living cell suspension is added to 
precursor mixture and followed by crosslinking upon addition of cysteine-flanked 
protease-cleavable peptide. 
                  
First, we varied the macromer concentration (or polymer wt%). In previous work, 
we showed that the elastic modulus of PEG-4MAL varied linearly with polymer wt% 
over the range of 4% - 10% (w/v), provided that ligand density was fixed [1]. Thus, we 
sought to investigate the relationship between macromer concentration (3.5% - 5.0%, 
<400 – 600 Pa) and cyst formation over 10 days in hydrogels formulated with 2000 μM 
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RGD and crosslinked with a fast-degrading cysteine-flanked peptide that contains the 
Coll I-derived sequence, GPQGIWGQ (GPQ-W). Eighteen hours after encapsulation, 
rounded single cells were incubated with calcein-AM (live) and TOTO-3 iodide (dead) to 
assess viability. High viability (>85%) was maintained in all conditions (Figure 3.2b). 
Within 48 hours of encapsulation, small, multicellular clusters were visible in gels of low 
wt% (<5.0% w/v) whereas high wt% gels had only single cells (Figure 3.2a). Epithelial 
cell clusters in 3D culture may form without proliferation via cell migration and 
aggregation [109, 123]. To determine whether early cluster formation involved 
proliferation, cells within gels were incubated with an alkyne-modified thymidine 
analogue, 5-ethynyl-2´-deoxyuridine (EdU). During six-hour incubations on day 2, 
dividing MDCK II cells incorporated EdU into newly synthesized DNA. Then, after 
fixation, samples were incubated with an azide-conjugated fluorophore that selectively 
reacted with the EdU alkyne in a Huisgen 1,3-dipolar cycloaddition and allowed 
detection of proliferation with fluorescence microscopy. The EdU incorporation assay 
confirmed widespread proliferation in those cultures where cell clusters were visible. 
Interestingly, although cell viability was high across all macromer concentrations, there 
was no cluster formation or proliferation at day 2 in gels with macromer concentration 
above 4.5% (Figure 3.2a,c).  
At day 2, the mean diameter of cellular specimens in 5.0% gels (12.34 ± 0.11 μm) 
was significantly smaller than objects in other PEG-4MAL gels (>17 μm, p < 0.0001), as 
the feret diameter measurement distinguished single cells in 5.0% gels from the 
proliferating clusters in all other conditions. Meanwhile, the mean diameter of clusters in 
Coll I gels exceeded 24 μm, significantly larger than that of all other conditions (p < 
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0.0001) (Figure 3.3a). Together, these results indicate that, within a permissive wt% 
range, PEG-4MAL hydrogels with adhesive ligand and degradable crosslinks support 
MDCK II proliferation in a 3D context. However, culture of MDCK II in PEG-4MAL 
hydrogels with wt% of 5.0% and above (data not shown) result in single cells throughout 
culture, providing no multicellular structures for study. Under these conditions, PEG-
4MAL hydrogels with wt% of 3.0% degrade rapidly and disintegrate before cultures are 
complete (data not shown). 
 
 
Figure 3.2. PEG-4MAL hydrogels support cyst morphogenesis. a, Single MDCK II 
cells were cultured in PEG-4MAL hydrogels of different polymer weight percentages and 
grew into clusters and cysts over 10 days. At day 2, newly synthesized DNA was labeled 
by incorporation of thymidine analogue EdU and detected by fluorescence microscopy. 
EdU-positive nuclei indicated with (^). Scale bar 50 µm. b, Quantification of cell 
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viability by calcein-AM (live) and TOTO-3 iodide (dead) labeling at day 1. At least 503 
cells counted per condition. c, Quantification of proliferation from EdU incorporation 
images. At least 596 nuclei counted per condition. d, Quantification of cyst size. *, 5.0% 
vs. all other conditions, p < 0.0001. **, Coll vs. all other conditions, p < 0.0001. Kruskal-
Willis test with Dunn’s multiple comparisons test. At least 131 objects counted per 
condition. 
 
At day 5, many clusters in 3.5%, 4.0%, and 4.5% PEG-4MAL gels contained 
hollow cavities that appeared to be the beginnings of lumens (Figure 3.3). It has been 
shown in MDCK cysts, and indeed in mammalian epithelial tubes in vivo, that lumen 
formation occurs by one of three mechanisms, including cavitation and hollowing [5, 
119, 123]. In Coll I gels, lumens form predominantly by cavitation, as cells at the interior 
of spheroids containing more than two cells are cleared via anoikis, a form of apoptosis 
due to estrangement from ECM. Alternatively, provided an early polarization signal (beta 
1 integrin binding of extracellular laminin, for instance), lumens form by hollowing, as 
fluid-filled vesicles are directed to the interface between cells at the two-cell stage [119, 
157]. MDCK cysts in Matrigel
TM
 typically form lumens by hollowing, as there is a strong 
polarization signal provided by laminin [157]. Additional observations in the literature 
include simultaneously appearing multiple lumens when signaling involving the small 
Rho GTPase cdc42 or vesicle trafficking proteins of the Rab family are perturbed [27, 
158]. In this instance, the hollowing mechanism is altered such that fluid-filled vesicles 
condense within cells and at non-central interfaces between cells in a growing cluster. To 
determine whether growing MDCK II cysts in PEG-4MAL gels contained apoptotic cells, 
we labeled cleaved caspase-3 in five-day old cysts. Antibody-based detection of cleaved 
caspase-3 confirmed that 20% – 32% of cysts in PEG-4MAL gels contained apoptotic 
cells at the time of assay (Figure 3.3). In Coll I gels, 17% of cysts were cleaved-caspase-
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3 positive. The fraction of cysts that contained apoptotic cells in PEG-4MAL gels varied 
inversely with polymer wt%. Fisher’s exact test showed the fraction of cleaved caspase-
3-positive cysts in 3.5% PEG-4MAL gels was significantly higher than in 4.5% or Coll I 
gels (p < 0.0156). There were no differences in comparisons between 4.0%, 4.5%, and 
Coll I gels (p > 0.9999).  
 
Figure 3.3. Cysts in PEG-4MAL hydrogels contain apoptotic cells. a, MDCK II cysts 
grown for 5 days in PEG-4MAL hydrogels with 2000 µM RGD and labeled with 
antibodies against apoptosis marker cleaved caspase-3. Fragmented nuclei indicated by 
(^). Scale bar 50 µm. b, Quantification of cysts having cleaved caspase-3 labeling at day 
5. At least 103 cysts counted per condition. 
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At day 10, the mean diameters of cysts in 3.5%, 4.0%, and 4.5% PEG-4MAL gels 
were 58.42 ± 1.30 μm, 58.64 ± 1.14 μm, and 57.34 ± 0.97 μm, respectively (Figure 3.2a, 
3.4b). However, there was no significant effect of PEG-4MAL wt% on size of cysts (p > 
0.8382). The mean diameter of cysts in Coll I was significantly than that of PEG-4MAL 
gels at day 10 (68.95 ± 1.60 μm, p < 0.0001).  
Establishment and maintenance of apico-basal polarity is a hallmark of epithelia. 
After 10 days of culture, MDCK II cysts embedded in Coll I gels are fully differentiated 
[92]. In a physiologically polarized mature cyst, apical polarity markers (e.g., 
podocalyxin) are segregated exclusively to the interior of the cyst, at the cell surface 
interfacing the lumen. To investigate the influence of PEG-4MAL wt% (3.5% - 5.0%) on 
apical polarity phenotypes of resulting cysts, we fixed MDCK II 3D cultures at day 10 
and labeled cysts with antibodies against apical polarity marker podocalyxin. Then, we 
captured cyst cross-sections with a confocal microscope and classified cysts into the 
following phenotypes: interior apical polarity, exterior apical polarity, mixed apical 
polarity, and no apical polarity. In PEG-4MAL gels, apical polarity phenotypes were 
modulated by polymer wt%. Whereas only 79% of cysts grown in 3.5% PEG-4MAL gels 
had internal polarity, 94% and 98% of cysts grown in 4.0% PEG-4MAL and 4.5% PEG-
4MAL gels had internal polarity, respectively. In Coll I gels, 97% of cysts had internal 
apical polarity. Furthermore, in 3.5% PEG-4MAL gels, 7% of cysts had exclusively 
external (or inverted) apical polarity. In contrast, only 2% of cysts grown in 4.0% PEG-
4MAL gels had external polarity and this inverted phenotype was not found in 4.5% 
PEG-4MAL gels or Coll I gels (Fig 3.4c.). We conducted a chi-squared test to compare 
the distributions of polarity phenotypes across PEG-4MAL gels of different wt%. In 
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summary, the distribution of polarity phenotypes in cysts grown in 3.5% PEG-4MAL 
gels differed significantly from the distributions found in cysts grown in 4.0% and 4.5% 
PEG-4MAL gels, respectively. Notably, the distribution of apical polarity phenotypes of 
cysts grown in 4.0% and 4.5% PEG-4MAL did not differ significantly from cysts grown 
in Coll I gels (Table 3.1). This result indicates that (1) PEG-4MAL hydrogels support 
establishment of apico-basal polarity in a manner similar to Coll I and (2) that the 
system’s weight percentage parameter modulates the apical polarity phenotype. We 
confirmed that other epithelial polarity markers including tight junction protein ZO-1, 
apically-oriented golgi matrix protein (GM130), and basolaterally-distributed β-catenin, 




Figure 3.4. PEG-4MAL weight percentage modulates cyst polarity and lumen 
phenotype. a, MDCK II cysts grown for 10 days and labeled with antibody against apical 
polarity marker podocalyxin (podxl). Inverted apical polarity indicated by (^). No cysts in 
5.0% condition. Scale bar 50 mm. b, Quantification of cyst size at day 10. *, Coll vs. 
3.5%, 4.0% or 4.5%: p<0.0001, one-way ANOVA with Tukey’s multiple comparison 
test. Adjusted p value.  c, Distribution of apical polarity phenotypes at day 10. At least 89 
cysts counted per condition. *, 3.5% vs. Coll: p = 0.0138, ns, 4.0% vs. Coll: p = 0.2289, 
4.5% vs. Coll: p = 0.5891, chi-squared test with Bonferroni’s correction. d, Distribution 
of lumen phenotypes at day 10. At least 89 cysts counted per condition. *, 3.5% vs. Coll: 
p = 3 x 10^-6, 4.0% vs. Coll: p = 0.0198, (ns, 4.5% vs. Coll: p > 0.9999), chi-squared test 





Table 3.1. PEG-4MAL weight percentage versus apical polarity phenotype distributions. 
Comparison Bonferroni’s test for 
multiple comparisons 
Χ2  df P^ 
3.5% vs. 4.0% S 12.58 3 0.0342 
3.5% vs. 4.5% S 22.46 3 0.0003 
4.0% vs. 4.5% NS 1.716 3 1.0000 
3.5% vs. Coll S 14.54 3 0.0138 
4.0% vs. Coll NS 0.2289 3 1.0000 
4.5% vs. Coll NS 0.5891 3 1.0000 
^P values adjusted for multiple comparisons. 
 
Table 3.2. PEG-4MAL weight percentage versus lumen phenotype phenotype distribution. 
Comparison Bonferroni’s test for 
multiple comparisons 
Χ2  df P^ 
3.5% vs. 4.0% NS 7.355 3 0.3684 
3.5% vs. 4.5% NS 10.82 3 0.0762 
4.0% vs. 4.5% NS 0.5619 3 1.0000 
3.5% vs. Coll S 31.79 3 3 x 10-6 
4.0% vs. Coll S 13.76 3 0.0198 
4.5% vs. Coll NS 0.5891 3 1.0000 
^P values adjusted for multiple comparisons. 
 
 
The cross-section of mature epithelial duct structure is a monolayer of cells 
surrounding a single, clear lumen. Studies in the literature typically classify MDCK II 
cysts in terms of lumen phenotypes in response to some genetic or chemical perturbation 
[5]. We investigated the distribution of cyst phenotypes among single lumen, partial 
lumen, multiple lumen, and no lumen in response to varying polymer wt% (3.5% - 5.0%). 
Nearly all (>97%) cysts formed in PEG-4MAL gels contained lumens (Figure 3.4d). In 
this respect, cysts in PEG-4MAL gels were comparable to those in Coll I gels. However, 
fewer than half of cysts in PEG-4MAL gels were characterized by a single clear lumen 
surrounded by a monolayer of cells, whereas ~51% of cysts in Coll I had single lumen. 
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Instead, cysts with partially-formed lumens or multiple cavities were dominant in PEG-
4MAL gels. Comparing PEG-4MAL gels of different wt%, the low wt% 3.5% PEG-
4MAL gels were less likely to have a single lumen than the 4.0% and 4.5% PEG-4MAL 
gels (17% vs. 31% and 35%, respectively). Likewise, 3.5% gels were more likely to have 
multiple lumens (59% vs. 46% and 44% for 4.0% and 4.5% gels, respectively) (Figure 
3.4d). We conducted a chi-squared test to compare the distributions of lumen phenotypes 
across PEG-4MAL gels of different wt%. Although the trend suggested an increasing 
incidence of single lumens and decreasing incidence of multiple lumens as wt% increased 
from 3.5% to 4.5%, the distribution of lumen phenotypes in cysts cultured in 3.5%, 4.0%, 
and 4.5% PEG-4MAL gels did not differ significantly from each other (Figure 3.4d.). 
However, when lumen phenotype distributions were compared between PEG-4MAL gels 
and Coll I, we found that 3.5% and 4.0% gels were significantly different from Coll I 
whereas 4.5% gels did not differ from Coll I (Table 3.2). This result indicates that PEG-




Figure 3.5. MDCKII cysts in PEG-4MAL gels express epithelial polarity markers with 




Figure 3.6. PEG-4MAL weight percentage modulates laminin (LM) basement membrane 
assembly. At day 10, cysts were incubated with an anti-LM antibody prior to fixation to 
label extracellular LM. Cysts scored on completeness of LM basement membrane. *, 
3.5% vs. 4.0% or Coll: p < 0.0001, 4.0% vs. Coll: p > 0.9999, Kruskal-Willis test with 
Dunn’s multiple comparisons test. 21 cysts counted per condition. Right panel: 
Representative images from PEG-4MAL gels. Scale bar 50 μm. 
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As cell-secreted extracellular laminin (LM) has been shown to define the axis of 
polarity in MDCK II cysts [53, 54], we sought to determine whether the inversion of 
polarity in 3.5% PEG-4MAL gels could be associated with abnormal LM deposition in 
the basement membrane. In confocal micrographs of mature MDCK cyst cross sections, 
we scored the completeness of the LM basement membrane. A continuous layer of LM at 
the perimeter of the cyst was scored as complete (1.0) whereas absence of the LM layer 
was scored 0.0 and partial coverage was scored 0.5. We found that nearly all cysts in 
4.0% PEG-4MAL gels and Coll I gels had complete LM basement membranes (Figure 
3.6). However, the mean LM deposition score for cysts in 3.5% gels was less than 0.4, 
significantly lower than that of 4.0% gels or Coll I gels (p < 0.0001), indicating disrupted 
basement membrane. There was no difference in the LM deposition scores when 4.0% 
gels and Coll I gels were compared. This result further establishes that PEG-4MAL 
hydrogels support lumen formation a manner similar to Coll I. 
Although variation of PEG-4MAL wt% affects hydrogel properties including 
elastic modulus, swelling ratio, and crosslink density, it does not systematically alter the 
hydrogel network structure. However, the molecular weight of the PEG-4MAL macromer 
can directly affect the distance between crosslinks in the hydrogel network. A macromer 
with shorter arms has less distance between crosslinks and generally results in higher 
elastic modulus and decreased swelling [147]. To investigate the influence of network 
structure on cyst morphogenesis in PEG-4MAL hydrogels, we embedded MDCK II cells 
in 4.0% (w/v) gels made with 10 kilodalton (kDa) PEG-4MAL or the 20 kDa PEG-
4MAL used in previous experiments and assayed proliferation after two days. All gels 
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were made with 1000 μM RGD. We found that proliferation was completely eliminated 
in 10 kDa PEG-4MAL gels (Figure 3.7). This result was reminiscent of MDCK II 
cultures in 20 kDa PEG-4MAL gels with wt% exceeding 4.5%, further establishing that a 
limited set of conditions are required to support MDCK II proliferation in synthetic 
matrix. 
 
Figure 3.7. PEG-4MAL molecular weight modulates MDCK II cell proliferation. MDCK 
II cells were cultured in 4.0% (w/v) hydrogels of 10 kDa or 20 kDa PEG-4MAL with 
1000 μM RGD and 100% GPQ-W crosslinker for two days. a, Dividing cells were 
labeled with EdU (red). Representative images. Scale bar 50 μm. b, Quantification of 




The preceding results were obtained using gels crosslinked with a fast-degrading, 
Coll I-derived peptide, “GPQ-W”, which contains the protease-sensitive sequence 
GPQGIWGQ. Hubbell and colleagues have previously shown that single amino acid 
changes of the protease- sensitive sequence alter the rate at which the peptide is cleaved 
[130]. In the context of a 4-arm PEG-vinyl sulfone hydrogel, the choice of crosslink 
peptide sequence influenced fibroblast migration in vitro and cranial bone regeneration in 
vivo. Thus, we wondered whether the degradation rate of the crosslink peptide sequence 
would modulate cyst morphogenesis in PEG-4MAL gels. We cultured MDCK II cells in 
4.0% PEG-4MAL hydrogels in which we titrated the concentration of GPQ-W with 
GPQGIAGQ (GPQ-A) peptide,  a peptide that degrades 2 – 7X slower than GPQ-W, 
depending on the matrix metalloproteinase (MMP) involved [159]. Cyst growth was 
completely abrogated in gels with 100% GPQ-A (0% GPQ-W), as evidenced by 
transmitted light images over 10 days (Figure 3.8). In fact, as little as 40% GPQ-A (60% 
GPQ-W), was sufficient to eliminate cyst growth. However, above a threshold GPQ-W 
concentration of 60%, there were no gross differences in the frequency or size of the 
epithelial cysts (Figure 3.8). Taken together, these results demonstrate that a threshold 
level of degradability is required for MDCK II proliferation and cyst formation in PEG-
4MAL hydrogels. 
Next, we sought to determine whether cyst growth in PEG-4MAL hydrogels was 
dependent upon MMP activity. We encapsulated MDCK II cells in growth-permissive 
4.0% PEG-4MAL gels with 100% GPQ-W and incubated the gels in culture media 
containing broad-spectrum MMP inhibitors GM6001 (25 μm) or MMP inhibitor II 
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(MMPII) (50 nM). GM6001 is a potent inhibitor of MMP-1, MMP-2, MMP-3, MMP-9, 
MMP-13, and MMP-14 [160-162]. MMPII is a potent inhibitor of MMP-1, MMP-3, 
MMP-7, and MMP-9 [163]. Transmitted light images show that cysts grown in the 
presence of 25 μM GM6001 were smaller and scarcer than those grown in 50 nM MMPII 
or DMSO (Figure 3.9a). Significantly, GM6001 is a potent inhibitor of MMP-2 while 
MMPII is not. MMP-2 is a gelatinase (cleaves denatured collagen) that is expressed in all 
parts of the kidney [164]. Thus, the difference between GM6001 and MMPII outcomes in 
this experiment, with each at a working concentration, is consistent with MMP-2-
mediated crosslink degradation. The cysts in MMPII, although large, seem to exhibit 
filled lumens. We observed similar results when MMPs were inhibited in Coll I gels 
(Figure 3.9b). Together, these results indicate that cyst growth in PEG-4MAL requires 




Figure 3.8. Crosslink degradation rate influences cyst growth in PEG-4MAL hydrogels. 
MDCK II cells were grown for 10 days in 4.0% PEG-4MAL hydrogels with 2000 μM 
RGD. Fast-degrading (GPQ-) and slow-degrading (GPQ-A) crosslinking peptides were 





Figure 3.9. MMP inhibition modulates cyst growth in PEG-4MAL hydrogels. MDCK II 
cells were grown for 10 days in 4.0% PEG-4MAL hydrogels with 2000 μM RGD and 
fast-degrading crosslinking peptide GPQ-W (a) or Coll I (b) in the presence of 25 μM 




Observations in 3D cultures of MDCK II in Coll I and Matrigel
TM
 have 
established a paradigm of epithelial polarization in which integrin receptors bind specific 
ECM motifs and subsequently transduce a signal that defines the axis of polarity. 
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Nevertheless, such approaches are limited by the “as-is” nature of the matrix materials. 
Furthermore, natural ECMs extracts are characterized by lot-to-lot variability, 
uncontrolled presentation of adhesive motifs, limited control of mechanical properties, 
and immunogenic potential when delivered in vivo. As a result, understanding the 
influence of ECM mechanics and degradation on 3D epithelial morphogenesis remains a 
major challenge. Therefore, a bioactive matrix with tunable mechanical properties and 
cell-responsive degradability could be a useful platform for elucidating key influences of 
ECM properties in tissue morphogenesis. Here, we present a PEG-based bioartificial 
hydrogel fabricated via well-characterized chemistry under physiological conditions that 
incorporates adhesive ligands with micromolar precision and allows cell-mediated 
remodeling of the network via protease-sensitive crosslinks. By culturing MDCK II 
epithelial cells in these engineered PEG-4MAL matrices over ranges of elastic moduli 
and crosslink densities, with varying degradation rates, and observing effects on 
proliferation, cyst size, apical polarity, and lumen phenotype, we demonstrate a platform 
for modulating MDCK II cyst morphogenesis in vitro. 
We previously reported Michael-reactive PEG-vinyl sulfone (PEG-4VS)-based 
hydrogels to modulate MDCK cyst morphogenesis [150]. More recently, a 
photocrosslinked PEG-acrylate-based hydrogel system was reported to study lung cancer 
spheroid morphogenesis in vitro [143]. However, the PEG-4MAL bioartificial matrix 
platform has several advantages over other PEG-based matrices for 3D culture epithelial 
cells. First, the robust Michael addition reaction involving maleimide and a free cysteine 
on a protein or peptide proceeds rapidly to completion, such that incorporated ligand 
density is limited only by pipetting precision. Similarly, the efficient reaction between 
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ligand-functionalized PEG-4MAL and cysteine-flanked crosslinking peptides allows 
hydrogel formation at wt% as low as 3.0%. This allows cultures in matrices exhibiting a 
wide range of elastic moduli [1]. Furthermore, the rapid (<15 min) crosslinking in PEG-
4MAL system requires only a low concentration of TEA (4 mM) in the PBS buffer. Other 
systems have required high TEA concentrations (>100 mM), additional buffer additives 
like HEPES, and photoinitiator-comonomer pairings like eosin Y and 1-vinyl-2 
pyrrolidinone (NVP) that complicate adjustment of macromer concentrations [142, 143, 
150, 165]. 
In the current study, we discovered a range of PEG-4MAL wt% (3.5% - 4.5%, 
w/v) in which embedded MDCK II cells exhibited robust proliferation and cysts 
development. Below 3.5%, gels degraded rapidly and disintegrated before the cultures 
were complete. Above 4.5%, cells did proliferate and only remained single cells 
throughout culture. In the growth-permissive wt% range, we found that cysts grown in 
3.5% gels were more likely to exhibit multiple lumens than those cultured in 4.0% and 
4.5% gels, in which the classic single lumen cyst was more prevalent. Similarly, 3.5% 
gels exhibited elevated incidence of cysts whose apical polarity was inverted versus the 
physiological orientation. Inspection of basement membranes surrounding mature cysts 
indicated that the departure from physiological cyst phenotype observed in 3.5% gels was 
associated with disrupted LM basement membrane deposition.  Importantly, we identified 
PEG-4MAL wt% conditions (4.0%, 4.5%) in which encapsulated MDCKII cells 
proliferate and form polarized cysts with lumens that closely resemble cysts grown in 
Coll I. 
51 
The initial growth of clusters in PEG-4MAL gels raised questions about the 
mechanism of cluster formation. In 3D cultures of primary human lung alveolar type II 
cells, hollow, polarized cysts formed from via aggregation without appreciable 
proliferation or apoptosis [109]. Somewhat similarly, the rate at which MDCK II formed 
clusters in Matrigel
TM
 scaled with seeding density, ostensibly due to aggregation, with 
implications for lumen formation [123]. We confirmed that MDCKII clusters grown in 
PEG-4MAL were forming via proliferation. Although the cell density used here in PEG-
4MAL gels (500 cells/μL) is an order of magnitude higher than that of Coll I gels (40 
cells/μL), the spacing between single MDCKII cells in highly-swollen PEG-4MAL is 
sufficient to prevent aggregation. Furthermore, our live cell imaging observations 
indicate that MDCKII cells in PEG-4MAL do little more than extend short projections 
and certainly do not migrate over appreciable distances (data not shown). MDCKII cysts 
in PEG-4MAL followed the morphogenetic pattern observed in Coll I gels, as solid 
clusters began to exhibit cavities after 4-5 days. Also similar to Coll I, PEG-4MAL gels 
induced apoptosis in cells at the interior of nascent cysts. These results suggest slow 
polarization with endogenous secreted LM providing the signal that establishes the axis 
of polarity [53-55, 123]. 
Currently, there is great interest in understanding how the mechanics of the 
microenvironment influence tissue homeostasis, particularly in the cases of epithelial 
organs where cancer progression has been associated with tissue stiffening [166]. It is 
well established that most healthy cells maintain a “tensional homeostasis” by generating 
cytoskeletal tension in response to stresses exerted by the microenvironment [166, 167]. 
Therefore, the linear relationship between elastic modulus and wt% observed in PEG-
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4MAL hydrogels, within the sub-kPa range, presents an attractive opportunity to 
investigate the influence of matrix mechanics on epithelial morphogenesis. However, for 
MDCK II cells, the range of cyst growth-permissive wt% is small (3.5% - 4.5%). 
Nevertheless, within the range analyzed in these studies (3.5% - 5.0%), there is 
considerable variation in key properties of the matrix. In terms of elastic modulus, 4.0% 
and 5.0% gels differ by only 200 Pa. (Elastic modulus was not measured for 3.5% gels.) 
However, there is reason to believe that 3.5% gels have significantly lower elastic 
modulus than 4.0% gels. The mass swelling ratio of 3.5% gels was three times higher 
than 4.0% gels and suggests a significantly looser network structure that typically 
corresponds with a low modulus [1]. Thus, the aberrant polarity and lumen phenotypes 
observed in 3.5% gels corresponds to a low (<<400 Pa) elastic modulus regime. In 
contrast, 4.0% and 4.5% gels in a higher (400 – 600 Pa) elastic modulus regime exhibited 
physiological cyst polarity and lumen phenotypes. We speculate that the high swelling in 
the 3.5% gel effectively decreases the density of adhesive ligands in the matrix and 
reduces the adhesive signal presented to the cells. A non-mutually exclusive alternative 
explanation is that the compliance of the 3.5% gel prevents generation of intracellular 
forces in response to contractility. The elimination of proliferation at high wt% could be 
explained by variations in other matrix properties, like crosslink density, that are 
influenced by wt%. 
PEG-4MAL hydrogels are modular systems in which stoichiometric combination 
of tetra-functional PEG-4MAL macromers and bi-functional crosslinking peptides yields 
a crosslinked network. Therefore, increasing the concentration (wt%) of PEG-4MAL 
necessitates an increase in the concentration of crosslinking peptides. In fact, the 
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concentration of crosslinks in a 5.0% PEG-4MAL gel is more than 60% higher than that 
of a 3.5% gel, with the same adhesive ligand density. We observed that MDCKII 
proliferation (but not viability) was eliminated in 5.0% PEG-4MAL gels, whereas 3.5% 
gels had robust proliferation. Our finding was consistent with earlier findings with 
mesenchymal cells spreading in PEG-4MAL gels fabricated with a fast-degrading 
crosslink peptide (GCRDVPMS↓YMRGGDRCG) where viable C2C12 myoblast 
(mesenchymal) spreading was inversely related to PEG-4MAL wt% [1]. The 
encapsulated cells are presented with an increasingly difficult burden of local degradation 
in order to divide or, in the case of mesenchymal cells, to spread. Although elastic moduli 
of 4.0%, 4.5%, and 5.0% PEG-4MAL gels are similar, we speculate that 5.0% gels 
exceed a threshold of crosslink density that permits proliferation. 
An increase in elastic modulus is observed when a lower molecular weight 
macromer (having shorter arms) is substituted at a given wt%. Nevertheless, the 
crosslinking density effect is not avoided, as a decrease in PEG-4MAL molecular weight 
from 20 kDa to 10 kDa, increases concentration of crosslink peptide by nearly 140%. In 
our study, MDCK II proliferation was eliminated when embedded in 4.0% 10 kDa PEG-
4MAL (vs. 20 kDa) gels. Together, these effects suggest that variation in PEG-4MAL 
wt% or molecular weight exert tremendous influences on crosslink density. As a result, 
the behavior of embedded cells may be modulated by the degradability of the crosslinks. 
Several groups have shown that degradability is critical parameter for modulating 
cell behaviors in synthetic matrices [130, 138, 141, 168]. For instance, cell migration is 
facilitated by local degradation, as cells forge a path through a dense matrix. Notably, 
Burdick and colleagues showed that degradable hyaluronic acid (HA) hydrogels directed 
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human mesenchymal stem cell (hMSC) differentiation toward an osteogenic phenotype 
whereas non-degradable HA hydrogels promoted an adipogenic phenotype independent 
of elastic modulus. In that instance, degradation allowed local remodeling of the 
microenvironment to enable assembly of focal adhesions and generation of traction that 
resulted in osteogenic differentiation [168]. In the present study, we showed that a fast-
degrading MMP-cleavable crosslink peptide is required for cyst growth in permissive 
wt% conditions. Titration of a slower-degrading peptide at 40% of the total crosslinking 
eliminated MDCK II cell proliferation. Furthermore, inhibition of MMP activity reduced 
cyst growth rates. Together, these results indicate that matrix degradation strongly 
influences MDCK II proliferation in PEG-4MAL. A non-mutually exclusive explanation 
for some of the proliferation-modulation effects attributed to crosslink density would be 
that, in the cases of increasing wt% or decreasing PEG-4MAL molecular weight, denser 
hydrogel networks inhibit nutrient diffusion and decreased cellular metabolic function. 
Lumen phenotypes in mature MDCKII cysts grown in Coll I gels and Matrigel
TM
 
are modulated by apical polarity complexes [123, 158, 169], Rho GTPase functions [27], 
vesicular trafficking machinery [158, 170], cell-cell adhesion [171, 172], apoptosis 
mediators [123], and cell seeding density [123]. How PEG-4MAL wt%, with its related 
effects on elastic modulus and crosslinking density, modulates lumen phenotype is likely 
related to effects on apico-basal polarity. Just as low PEG-4MAL wt% (3.5%) gels 
exhibited higher incidence of cysts with multiple lumens versus higher wt% (4.0%, 4.5%) 
gels, low wt% gels produced cysts with higher incidence of exterior or mixed polarity. 
Cysts grown from culture of MDCK cells in suspension also exhibit external apical 
polarity [95-97]. This owes to absence of cell anchorage to matrix via integrin receptors 
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on the external surface of cyst. As the suspension microenvironment provides no spatial 
context, the cysts produce an apical surface on the outside and secrete LM into a central 
lumen, if lumens exist. In this PEG-4MAL culture case, the decreased crosslinking 
density in the low wt% gels may result in accelerated disintegration of the matrix with its 
integrin binding ligands. Thus, to some extent, cysts in low wt% gels may have adopted a 
suspension phenotype. The implications for lumen formation may relate to laminin 
secretion into the lumen and increased luminal cell survival. In fact, we observed LM 
staining at the interior of some cysts grown in 3.5% gels (Figure 3.6, bottom-right 
panel). Together, our observations of MDCK II proliferation, cyst polarization, and 
lumen formation strongly suggest that matrix degradability, which can be modulated by 
crosslink density, exerts a major influence on epithelial morphogenesis within PEG-
4MAL hydrogels. We suppose that increasing cell density from 500 cells/μL to levels 
used in similar studies (1000-2000 cells/μL) [143, 150, 173] might allow cell 
proliferation in higher wt% gels and gels made with short-arm macromers, as the 
secretion of MMPs would be increased. 
 
Conclusions 
We have exploited a highly-efficient Michael-reactive PEG macromer to fabricate 
bioartificial hydrogels that incorporate cell adhesion ligands, permit cell-responsive 
degradation, and exhibit elastic properties resembling natural ECM extracts. By culturing 
MDCK II epithelial cells in these engineered PEG-4MAL matrices over a range of 
polymer wt%, we showed that the elastic modulus, crosslink density and degradability of 
the matrix effectively modulate cell proliferation and cyst morphogenesis (establishment 
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of apical polarity and formation of lumens). Furthermore, we demonstrated a flexible 
platform for modulating epithelial morphogenesis in vitro. In summary, bioartificial 
matrices stand as an experimental and therapeutic platform offering excellent control of 
the physical and biological properties of the microenvironment for studies of tissue 
morphogenesis. 
 
Materials and Methods 
Antibodies (and other reagents) 
The following primary monoclonal (mAb) and polyclonal (pAb) antibodies were used: 
Mouse anti-gp135/podocalyxin (supernatant 3F2 1D8, kind gift of G. Ojakian, SUNY 
Downstate), rabbit anti-laminin (LM) (Sigma-Aldrich, St. Louis, MO). Anti-LM antibody 
was raised against intact LM-111, consisting of α1-, β1-, and γ1-chains, and may also 
detect other LM isoforms consisting of those chains (e.g., LM-511) [53, 54]. The 
following secondary antibodies were used: goat anti-mouse IgG Alexa Fluor 488, goat 
anti-rat IgG Alexa Fluor 555, goat anti-rabbit IgG Alexa Fluor 488 (Life Technologies, 
Carlsbad, CA), donkey anti-rabbit IgG Dylight 649 (Thermo Fisher Scientific, Rockford, 
IL). Nuclei were stained with Hoechst 33342 and filamentous actin was stained with 
rhodamine phalloidin (Life Technologies). Synthetic adhesive peptide GRGDSPC, and 
crosslink peptides GCRDGPQGIWGQDRCG and GCRDGPQGIAGQDRCG were 
obtained from aapptec, (Louisville, KY). MMP inhibitors GM6001 and MMP inhibitor II 




Madin-Darby canine kidney (MDCK) strain II epithelial cells (ECACC via Sigma-
Aldrich) were maintained in Eagle’s minimal essential media (EMEM) (ATCC, 
Manassas, VA) supplemented with fetal bovine serum (Life Technologies) at 10% (v/v), 
Penicillin (100 IU/mL, Life Technologies) and streptomycin (100 μg/mL, Invitrogen) and 
fungizone (Invitrogen). 
 
Three-dimensional cell culture in PEG-maleimide hydrogels 
For 5.0% (w/v) hydrogels, four-arm PEG-maleimide (PEG-4MAL) (MW = 22000, 
Laysan Bio, Arab, AL) was dissolved in diH20 at 12.5% (w/v) and desalted using a 7 
kDa MW cutoff column (Zeba, Thermo Fisher Scientific, Waltham, MA). After 
lyophilization, desalted PEG-4MAL was dissolved in a triethanolamine (TEA) (Sigma-
Aldrich) buffer (4 mM in DPBS, pH 7.4) to form a 12.5% solution (w/v) (2.5X the final 
5% hydrogel). Dilutions for lower wt% gels were made at this step. Adhesive peptide 
(GRGDSPC) was dissolved in TEA (to form 10 mM peptide solution). Two volumes of 
PEG-4MAL precursor solution was mixed with one volume of peptide solution. The 
mixture was incubated at room temperature for at least 10 minutes to achieve 
functionalized PEG-4MAL precursor. Bis-cysteine crosslinking peptide 
(GCRDGPQG↓IWGQDRCG) (GPQ-W) (↓denotes enzymatic cleavage site) or 
GCRDGPQG↓IAGQDRCG was dissolved in TEA at concentration that achieves 1:1 
maleimide:cysteine ratio after accounting for maleimide groups reacted with adhesive 
peptide. Actively growing MDCK cells were trypsinized, counted and resuspended at 5x 
final cell density in ice-cold serum-free EMEM and stored on ice. 12-well silicone 
isolator sheets (4.5 mm diameter well, 1 mm thick, Grace Bio-Labs, Bend, OR) were 
pressed onto microscope slides and exposed glass was treated with Sigmacote (Sigma-
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Aldrich). To form 20 μL gels, 4 uL of crosslinker solution was pipetted into each well. 
Then, 4 uL of cell suspension was mixed with 12 μL of functionalized PEG-4MAL 
precursor solution. 16 μL PEG-cell mixture was then pipetted into well and mixed 10-15 
times. Gelation was apparent within 30 seconds. Gels were moved to 37C, 5% CO2 
humidified incubator for 20-25 minutes to facilitate crosslinking. Gels were then swelled 
in complete growth media and moved to 48-well plate with 0.5 mL complete growth 
media per well.  
 
Three-dimensional cell culture in type I collagen gels 
To prepare a 2 mg/mL neutral type I collagen solution, eight parts type I collagen from 
bovine tendon (3 mg/ mL, Sigma-Aldrich) was mixed with one part 10X DMEM on ice 
(see below) and the pH adjusted to 7.2 – 7.6 using 0.1M NaOH. A cell suspension in 
serum-free media was added to the mixture to dilute the solution to 2 mg/mL type I 
collagen and result in 40,000 cells/mL. 150 µL of the cell-collagen mixture was added to 
the wells of an 8-well chambered coverglass. Collagen gel was allowed to solidify for 30 
– 45 minutes in a 37° C air incubator. 200 μL complete media added to each well. 
Alternatively, 75 µL of the cell-collagen mixture was pipetted onto a 6.5 mm polyester 
permeable support (0.4 μm pore, Corning, Corning, NY) in a 24-well plate. 700 µL 
complete media was added to the bottom reservoir and 200 µL was added to the top 
reservoir after gel solidified.  
 
Viability assays 
To assay viability of cells within bioartificial matrix: PEG-4MAL gels were moved to 96-
well plate, culture medium removed and replaced with 125 µL of 0.5% collagenase I 
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(1250 U/mL, Worthington Biochemical, Lakewood, NJ), 2 μM calcein-AM (LIVE)(Life 
Technologies), 1 μM TOTO-3 iodide (DEAD)(Life Technologies) in serum-free EMEM 
media. Plate incubated at 37° C in 5% CO2 in humidified incubator for approximately 60 
minutes or until hydrogel was completely dissolved and cells settled at bottom of well. 
For collagen gels, gel was incubated in 2 μM calcein-AM and 1 μM TOTO-3 for 30 
minutes and placed in chambered coverglass for imaging. Samples imaged at 10x or 20x 
with C-1 or C-2 inverted confocal fluorescence microscope (Nikon, Melville, NY) and 




Proliferation was assayed using the Click-iT EdU Imaging Kit (Life Technologies) with 
adaptations of manufacturer’s instructions. Briefly, 5-ethynyl-2´-deoxyuridine (EdU), a 
thymidine analogue, was added to hydrogel culture media at 10 μM for 6 – 8 hours. 
Samples were then fixed and treated with the appropriate kit reagents to label all nuclei 
with Hoechst 3342 and proliferating nuclei with an Alexa Fluor dye. Then, PEG-4MAL 
gels were dissolved and mounted in 0.5% collagenase I (1250 U/mL, Worthington 
Biochemical) in 2% low-melt agarose (Lonza, Walkersville, MD) at 37C in chambered 
coverglass. After cells and clusters settled to bottom of wells, agarose was allowed to 
solidify at 4C. For collagen gels, gel was mounted on microscope slide with ProLong 
Gold (Life Technologies) and #1.5 coverslip. Samples imaged at 10x or 20x with C-1 or 
C-2 inverted confocal fluorescence microscope (Nikon, Melville, NY) and cells counted 
with ImageJ macros. 
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Immunofluorescence labeling of cysts 
Gels were washed extensively in PBS+ (3x quickly and 2x 5 minutes) to remove media 
and fixed in 4% formaldehyde in PBS+ for 15 minutes while rocking at room 
temperature. After extensive washing in PBS+, gels were incubated 30 minutes in 
blocking buffer (1% bovine serum albumin, 1% goat serum, 0.1% fish skin gelatin, 0.5% 
Triton X-100, 0.05% sodium azide in PBS). Meanwhile primary antibodies were diluted 
in blocking buffer. Mouse anti-gp135 supernatant was used at 1:10 – 1:100 dilution and 
all others were used at 1:100. In a 48-well plate or 8-well chambered coverglass, 200 μL 
of primary antibody solution was added to each PEG-4MAL gel and PBS+ added to 
empty wells for humidity. Plates were sealed with parafilm and placed on orbital shaker 
at 4C overnight. After extensive washing in blocking buffer, secondary antibodies and 
nuclear stain were diluted in blocking buffer and added to gels. All fluorescently-labeled 
secondary antibodies were used at 1:200 dilution, rhodamine phalloidin at 1:50, and 
DAPI nuclear stain was used at 1:1000 dilution. Secondary antibody incubation 
proceeded overnight as described for primary antibody. After further washing in blocking 
buffer, gels were washed in PBS+ and post-fixed for 15 minutes in 4% paraformaldehyde 
in PBS+. Gels were again washed in PBS+ and stored in PBS+ with sodium azide at 4C 
protected from light. To label extracellular laminin, the appropriate primary antibody was 
added to the culture media at 1:50 for four hours prior to fixation. 
 
Cyst collection in agarose gel for imaging 
Following immunofluorescence labeling, each gel was placed in well of 8-well 
chambered coverglass (1.0 thickness, Thermo Fisher Scientific) and 250 μL of 0.1% 
collagenase I (250 U/mL, Worthington Biochemical) in 2% low-melt agarose (Lonza) in 
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PBS. After several hours incubation on shaker at 37C, cysts were released to bottom of 
well and chambers were moved to 4° C refrigerator for agarose to solidify. 
 
Microscopy 
Phase contrast images were captured daily during the course of three-dimensional 
cultures using an inverted microscope (Nikon) and SPOT imaging software (Diagnostic 
Instruments, Sterling Heights, MI). Fluorescent images for cyst scoring were captured 
using a C1 or C2 laser scanning confocal microscope with a 20x  or 60x objective and 
EZ-C1 or NIS Elements software (Nikon, Melville, NY). Each field contained up to 
dozens of cysts. A single z-slice was captured at an appropriate plane. Each image was 
captured as the merge of four separate channels corresponding to blue, green, red, and 
transmitted light, respectively. 
 
Quantitation of cyst morphology 
For multiplicity of lumens: a cyst cross-section having a single hollow space and outlined 
by a monolayer of cells was designated as having a single lumen, a cyst cross-section 
having a single hollow space bounded by multiple layers or groups of cells was 
designated as having a partial lumen, a cyst cross-section having multiple hollow spaces 
was designated as having multiple lumens, and a cyst cross-section having no hollow 
spaces was designated as having no lumen. 
For polarity: a cyst cross-section in which the interior of lumens are lined with gp135 and 
the exterior of cyst lacks gp135 possessed interior apical polarity, a cyst cross-section in 
which the interior of lumens lack gp135 and the exterior of cyst is lined with gp135 
possessed exterior apical polarity, a cyst cross-section in which the interior of lumen and 
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the exterior of cysts showed similar accumulation of gp135 possessed mixed apical 
polarity. A continuous layer of LM at the perimeter of the cyst was scored as complete 
(1.0) whereas absence of the LM layer was scored 0.0 and partial coverage was scored 
0.5. Cyst size was measured from fluorescent images of cyst cross sections. Minimum 
and maximum feret diameters were measured for each cysts using ImageJ and the 
average was reported. See [174]. 
 
Statistical Analysis 
For continuous variable data, we used one-way ANOVA with Tukey’s tests for multiple 
comparisons, where necessary. For categorical data, we implemented a chi-squared test 
with Bonferroni’s test for multiple comparisons, where necessary (See [175]). GraphPad 
Prism software (GraphPad, La Jolla, CA) was used to implement analyses. 
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CHAPTER IV:  INFLUENCE OF INCORPORATED ADHESIVE LIGAND 
CONCENTRATION ON CYST MORPHOGNESIS OF MDCK II EPITHELIAL 




Three-dimensional (3D) cell cultures in natural ECM extracts, including type I 
collagen (Coll I) and Matrigel
TM
, enable observation of epithelial morphogenesis, a hard-
wired, multicellular differentiation program that integrates cell-ECM adhesion, cell 
proliferation, and ECM remodeling to achieve functionally differentiated structures like 
hollow cysts and tubules [81, 86, 87, 89, 119]. Nevertheless, critical limitations of natural 
ECM extracts, including clinical incompatibility, lot-to-lot variability and undefined 
presentation of cell adhesion motifs have motivated development of a synthetic ECM 
platform for detailed studies. Here, a multi-arm poly (ethylene glycol) (PEG)-maleimide 
macromer (PEG-4MAL) is covalently functionalized with adhesive peptides and 
crosslinked with proteolytically-cleavable peptides in the presence of epithelial cells. A 
highly-efficient Michael-addition reaction enables fabrication of hydrogels with defined 
quantities of RGD peptide while keeping all other hydrogel properties unchanged [1]. By 
culturing MDCK II epithelial cells in these engineered PEG-4MAL matrices over a range 
of incorporated RGD concentration (0 – 2000 μM), we show that cyst size, apical 
polarity, and lumen phenotypes are remarkably sensitive to adhesive ligand density. 
Introduction 
Organization of epithelial cells into polarized, 3D tissue structures is critical to the 
barrier, secretion, and exchange functions of organs including lung, kidney, intestine and 
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salivary gland. Disruption of the 3D structure or dysregulation of the polarity in epithelial 
tissues is associated with significant morbidity and mortality [155]. When epithelial cells, 
including MDCK, are encapsulated in Coll I gels, hollow spherical monolayer structures 
called cysts form within 10 days and bear the hallmarks of epithelial polarity [92, 95, 96, 
156]. Such 3D cultures of epithelial cells in natural ECM extracts have revealed that 
development and maintenance of intricately ordered epithelial structures (a process 
termed epithelial morphogenesis) involves coordination cell fate processes including 
adhesion, migration, differentiation, polarization, and apoptosis. Furthermore, these 
studies have revealed a powerful role of ECM in a framework of bi-directional signaling 
where cells embedded in matrix sense the adhesive signals in the matrix while actively 
remodeling the matrix via proteolytic degradation and secretion of new matrix [24, 35, 
53, 65]. Specifically, β1 integrin receptors bind specific ECM motifs and subsequently 
transduce a signal that culminates in secretion of laminin at the basal surface where β1 
integrin binding defines the axis of polarity. The cell surface interfacing the ECM is thus 
established as “outside” and the opposite cell surface is defined as “inside” [25, 54]. 
Integrin binding is so critical that blockade of β1 integrin binding results in major 
departures from the mature MDCKII cyst phenotype [53]. Thus, 3D culture of epithelial 
cells in natural ECM extracts is a critical tool for studying development and maintenance 
of tissue architecture and the implications in organ function and pathogenesis. 
Despite progress in these areas, studies of epithelial morphogenesis in natural 
ECMs are limited by the uncontrolled presentation of adhesive ligands, limited control of 
matrix structural and mechanical properties, lot-to-lot variability, and concerns over 
clinical use of animal-derived materials. In contrast, an engineered synthetic matrix that 
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specifically and precisely presents biological functionality, with tunable elastic 
properties, could be a useful platform for elucidating key influences of ECM properties in 
tissue morphogenesis. PEG hydrogels are the gold standard for cell- and tissue-interactive 
synthetic biomaterials, owing to hydrophilicity that results in highly-swollen gels with 
tissue-like properties, non-fouling character that presents a “clean slate” to biological 
systems, and excellent acceptance in vivo [129]. For this reason, cell-encapsulating 
hydrogels that present cell adhesion ligands and protease-sensitive crosslinking peptides 
have found broad experimental applications including regulation of cell migration, 
therapeutic vascularization, and stem cell differentiation [1, 130-133, 136, 152]. We 
previously showed that PEG-based hydrogel systems could support MDCK cyst 
morphogenesis [150]. Here, we present a four-arm PEG-maleimide (PEG-4MAL)-based 
system that offers superior reaction efficiency, a wide range of achievable elastic 
properties, and cell-responsive degradation as a bioartificial matrix to modulate epithelial 
morphogenesis. By culturing MDCK II epithelial cells in these engineered PEG-4MAL 
matrices over a range of adhesive ligand densities and observing dramatic effects on cyst 
size, apical polarity, and lumen phenotype, we examine the effect of adhesive ligand 
density on epithelial morphogenesis program. 
 
Results 
Many cell fate processes including proliferation, migration, and differentiation are 
regulated by integrin binding of specific ECM ligands [176]. In fact, beta1 integrin 
binding to collagen and laminin are critical events in formation of hollow, polarized cysts 
in collagen gels and Matrigel
TM
 [53-55]. Furthermore, the fibronectin (and laminin-) 
derived arginine-glycine-aspartate (RGD) tripeptide is bound by integrins αvβ3 and α5β1, 
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among others, and has been used extensively in engineered systems [177]. RGD density 
has been shown to modulate cell proliferation, migration, differentiation  in a variety of 
systems [177]. In previous work, we demonstrated that a cysteine-containing cell 
adhesive peptide (GRGDSPC) can be incorporated into PEG-4MAL gels with high 
precision. With a reagent that detects free thiols on the unconjugated cysteines, we 
observed rapid and complete conjugation of GRGDSPC [1]. In contrast, using PEG 
hydrogels with different reactive groups like vinyl sulfone or acrylate, ligand 
incorporation was slow and failed to reach completion, even with high concentrations of 
triethanolamine (TEA) [1]. To understand whether RGD concentration in PEG-4MAL 
hydrogels influences epithelial cyst development, we cultured MDCK II cells within 
4.0% PEG-4MAL gels with 0 – 2000 μM RGD and the fast-degrading crosslink peptide 
that includes the sequence GPQG↓IWGQ (↓ indicates cleavage site) (Figure 4.1). Over 
10 days, we assayed cell survival and cell proliferation, measured cyst size, and classified 
cyst lumen and apical polarity phenotypes. The 4.0% PEG-4MAL parameter was chosen 
to employ microenvironments in the middle of the proliferation-permitting range 
(chapter III). To avoid a departure from the hydrogel structure used in previous studies 
within this investigation, we maintained a 2000 μM overall ligand loading. Thus, to vary 
RGD concentration, we added a quantity of non-adhesive RDG peptide equal to the 
amount that RGD concentration was reduced from 2000 μM. Therefore, in each gel, 
[   ]          [   ]. 
At day 10, cultures were fixed, labeled with antibodies against apical polarity marker 
podocalyxin and laminin, stained for f-actin and DNA, and imaged by confocal 
microscopy (Figure 4.2a). The mean feret diameter of cysts ranged from 48.1 ± 1.3 μm 
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in 0 μM RGD gels to 74.9 ± 1.7 μm in 250 μM RGD gels (Figure 4.2b.). Cysts in 0 μM 
RGD gels were significantly smaller than cysts in other gels containing as little as 10 μM 
RGD (p<0.0004, ANOVA with post-test corrected by Bonferonni’s method). This result 
indicates that precise control of adhesive ligand presentation in PEG-4MAL hydrogels 
can modulate MDCK II cyst size. 
With a microenvironment that can be precisely tailored to present specific 
quantities of an integrin-binding ligand, we investigated the effects of RGD incorporation 
in PEG-4MAL hydrogels on MDCK II cyst apical polarity. Cysts were classified into the 
following phenotypes: interior apical polarity, exterior apical polarity, mixed apical 
polarity, and no apical polarity (Figure 4.2d). Strikingly, the distribution of apical 
polarity phenotypes underwent a major shift at 250 μM RGD. For gels with low RGD 
concentration (≤ 100 μM), the majority of cysts had exterior apical polarity, which is 
inverted relative to the polarity in natural ECMs. In contrast, gels with high RGD 
concentration (≥ 250 μM) produced cyst populations in which the exterior apical polarity 
phenotype was rare. Instead, the physiological internal apical polarity phenotype was 
dominant in high RGD gels. Nevertheless, a small number of cysts with internal apical 
polarity were present in gels with as little as 50 μM RGD. We conducted a chi-squared 
test to determine how RGD incorporation in a 4.0% PEG-4MAL hydrogel affected the 
distribution of apical polarity phenotypes. We found that incorporated RGD 
concentration of 50 μM or more was sufficient to significantly alter the distribution of 
apical polarity phenotypes compared to gels with 0 µM RGD (p<0.0001). Whereas 
polarity phenotype differences between 50 μM and 100 μM were not significant (p 
=1.0000), a statistically significant shift in polarity phenotype distributions occurred 
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between 100 μM and 250 μM (p<0.0001). Next, we compared the apical polarity 
distributions in all concentrations of RGD to the Coll I gel. Notably, the population of 
cysts in PEG-4MAL gels containing 2000 μM RGD was not significantly different from 
that in the Coll I gel (p=0.2388). These results establish that (1) MDCK II cyst 
morphogenesis in PEG-4MAL hydrogels is highly sensitive to incorporated RGD 
concentration and that (2) RGD density in PEG-4MAL hydrogel can be tuned to induce 
cyst phenotypes resembling those observed in Coll I gels. 
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Figure 4.1. Concentration of incorporated RGD in PEG-4MAL hydrogel modulates 
MDCK II proliferation. a, Single MDCK II cells were cultured in 4.0% PEG-4MAL 
hydrogels incorporating different amounts of GRGDSPC peptide and grew into clusters 
and cysts over 10 days. Scale bar 50 μm. 
 
To examine the influence of RGD concentration on the distribution of cyst lumen 
phenotypes in 4.0% PEG-4MAL gels, we classified 10-day-old cysts among no lumen, 
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partial lumen, single lumen, and multiple lumen in response to varying RGD 
concentration (0 – 2000 μM RGD). For gels with low RGD concentration (≤ 100 μM), 
the majority of cysts had no lumen (Fig 4.2c.). In an effect similar to that observed with 
apical polarity phenotypes in response to RGD concentration, a major shift in the 
distribution of lumen phenotypes occurred at 250 μM RGD. In gels with high RGD 
concentration (≥ 250 μM), cysts with no lumen were rare. Whereas cysts with single 
lumen were completely absent in low RGD gels, single lumen cysts made up a small 
proportion of the population in high RGD gels. Cysts with multiple lumens were 
dominant in the high RGD gels (Fig 4.2c.). We conducted a chi-squared test to determine 
how RGD incorporation in a 4.0% PEG-4MAL hydrogel affected the distribution of 
lumen phenotypes. Incorporated RGD concentration of 50 μM or more was sufficient to 
significantly alter the distribution of lumen phenotypes compared to gels with 0 µM RGD 
(p<0.0001). Whereas lumen phenotype differences between 50 μM and 100 μM were not 
significant (p =1.0000), a statistically significant shift in lumen phenotype distributions 
occurred between 100 μM and 250 μM (p<0.0001). This result further establishes that 
MDCK II cyst morphogenesis in PEG-4MAL hydrogels is highly sensitive to 
incorporated RGD concentration. 
Developing MDCK cysts in Coll I assemble a basement membrane such that 
labeling mature cysts with anti-LM antibodies reveals a thin layer of secreted LM at the 
periphery of the cyst [53-55, 104]. To determine whether RGD concentration in PEG-
4MAL hydrogels modulated LM basement membrane assembly, we labeled extracellular 
LM in cysts grown in gels presenting 0 – 2000 μM RGD. We observed that LM was 
patchy or diffuse in gels presenting 0 – 1000 μM RGD. In contrast, cysts in 2000 μM 
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RGD and Coll I gels exhibited dense and continuous LM basement membranes (Figure 
4.3). This result further establishes that tuning RGD concentration in PEG-4MAL 
hydrogels modulates cyst morphogenesis and approximates cyst phenotypes observed in 
natural ECM. 
The importance of β1 integrin binding in MDCK II cyst morphogenesis in Coll I 
gels is well-established through the use of function-blocking antibodies [53, 103]. 
Whereas α5β1 integrin binds RGD motifs in the context of FN protein where synergy 
binding sequences are present, the isolated, linear RGD peptide is primarily bound by 
αVβ3 [178]. To explore the dependence of cyst morphogenesis in PEG-4MAL matrix on 
αVβ3 binding, we cultured MDCK II cells in PEG-4MAL in the presence of LM609, an 
αVβ3 function-blocking antibody. We observed that LM609 caused an inversion of 
polarity resembling that seen in cultures lacking RGD. Notably, the LM basement 
membrane was intact and unaffected by LM609 (Figure 4.4). 
Next, to explore the role of β1 integrin binding in MDCK II cyst morphogenesis 
in the context of a synthetic matrix presenting only RGD, we cultured MDCK II cells in 
PEG-4MAL in the presence of AIIB2, a β1 integrin function-blocking antibody. We 
observed undefined cyst polarity evidenced by diffuse podocalyxin labeling, absent 
lumen, and diffuse LM basement membrane labeling. Together, these integrin blocking 
results indicate αVβ3 binding drives physiological cyst polarization in RGD-conjugated 
PEG-4MAL gels and that β1 binding is required for both polarization and LM basement 




Figure 4.2. Concentration of incorporated RGD in PEG-4MAL hydrogel modulates 
cyst phenotype and apical polarity. a, MDCK II cysts grown in 4.0% PEG-4MAL for 
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10 days and labeled with antibody against apical polarity marker podocalyxin (podxl). 
Inverted apical polarity indicated by (^). Scale bar 50 µm. b, Quantification of cyst size at 
day 10. At least 62 cysts counted per condition. *, 0 µM RGD vs. every [RGD] (µM) 
other condition except 2000 µM RGD, p < 0.05, one-way ANOVA with Dunnett’s 
multiple comparisons test. c, Distribution of apical polarity phenotypes at day 10. At least 
78 cysts counted per condition. *, 0 µM RGD vs. every other condition except 10 µM 
RGD, p < 0.0001. **, Coll vs. every other condition except 2000 μM RGD, p<0.0001, 
chi squared test with Bonferroni’s correction for multiple comparisons. d, Distribution of 
lumen phenotypes at day 10. At least 78 cysts counted per condition. *, 0 µM RGD vs. 
every other condition except 10 µM RGD, p < 0.0001. **, Coll vs. every other condition, 
p<0.0001, chi squared test with Bonferroni’s correction for multiple comparisons. 
 
 
Table 4.1. Incorporated RGD concentration versus apical polarity phenotype distributions. 
Comparison Bonferroni’s test for 
multiple comparisons 
Χ2  df P^  
0 μM vs. 10 μM NS 7.266 3 0.7668 
0 μM vs. 50 μM S 91.59 3 <10-6 
0 μM vs. 100 μM S 61.06 3 <10-6 
0 μM vs. 250 μM S 452.116 3 <10-6 
0 μM vs. 1000 μM S 410.2 3 <10-6 
0 μM vs. 2000 μM S 543.2 3 <10-6 
0 μM vs. Coll S 367.0 3 <10-6 
50 μM vs. Coll S 174.4 3 <10-6 
100 μM vs. Coll S 179.4 3 <10-6 
250 μM vs. Coll S 67.7 3 <10-6 
1000 μM vs. Coll S 36.00 3 <10-6 
2000 μM vs. Coll NS 9.846 3 0.2388 




Table 4.2. Incorporated RGD concentration versus lumen phenotype distributions. 
Comparison Bonferroni’s test for 
multiple comparisons 
Χ2  df P 
0 μM vs. 10 μM NS 0.5635 3 1.0000 
0 μM vs. 50 μM S 85.03 3 <10-6 
0 μM vs. 100 μM S 53.84 3 <10-6 
0 μM vs. 250 μM S 528.5 3 <10-6 
0 μM vs. 1000 μM S 409.7 3 <10-6 
0 μM vs. 2000 μM S 529.0 3 <10-6 
0 μM vs. Coll S 430.0 3 <10-6 
10 μM vs. Coll S 269.0 3 <10-6 
50 μM vs. Coll S 175.3 3 <10-6 
100 μM vs. Coll S 210.6 3 <10-6 
250 μM vs. Coll S 148.6 3 <10-6 
1000 μM vs. Coll S 71.23 3 <10-6 
2000 μM vs. Coll S 30.70 3 <10-6 





Figure 4.3. Concentration of incorporated RGD in PEG-4MAL hydrogel influences 
laminin basement membrane deposition. MDCK II cysts grown in 4.0% PEG-4MAL 
for 10 days and incubated for four hours with antibody against laminin prior to fixation 





Figure 4.4. Cyst development in PEG-4MAL hydrogel depends on integrin binding. 
MDCK II cysts grown in 4.0% PEG-4MAL for 10 days in the presence of function-
blocking antibodies against β1 integrin (AIIB2, rt IgG) or αVβ3 (LM609, ms IgG) or 





Whereas 3D cultures of epithelial cells in natural ECM extracts have elucidated 
fundamental aspects of morphogenesis of epithelial tissue structures, such approaches are 
limited by the “as-is” nature of the matrix materials. Natural ECMs extracts are 
characterized by lot-to-lot variability, uncontrolled presentation of adhesive motifs, 
limited control of mechanical properties, and immunogenic potential when delivered in 
vivo. In contrast, a tailorable matrix that specifically and precisely presents biological 
functionality represents a useful and powerful platform for elucidating key influences of 
ECM properties in epithelial morphogenesis. Here, we present a PEG-based bioartificial 
matrix fabricated via well-characterized chemistry under physiological conditions that 
incorporates adhesive ligands with high precision and allows cell-mediated remodeling of 
the network via protease-sensitive crosslinks. By culturing MDCK II epithelial cells in 
these engineered PEG-4MAL matrices over a range of RGD adhesive ligand densities 
and observing dramatic effects on cyst size, lumen phenotype, and apical polarity, we 
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demonstrate a platform for modulating epithelial morphogenesis in vitro. The robust 
Michael-addition reaction allows fabrication of PEG-4MAL-based hydrogels with 
stoichiometric ligand incorporation. By blending in a non-adhesive, scrambled peptide 
(RDG), we varied RGD concentration over three orders of magnitude without altering the 
total ligand loading and thus maintained hydrogel structure. 
To understand how adhesive ligand density modulates epithelial cyst morphology, we 
compared cyst size, apical polarity phenotypes and lumen phenotypes of cysts grown in 
gels presenting a range of adhesive ligand concentrations. This system enabled us to 
identify RGD concentrations required for physiological apico-basal polarization and 
lumen formation over 10 days. Strikingly, we observed dramatic phenotypic shifts 
triggered by RGD concentration increments as small as 10 μM. Although cysts of 
substantial size grew in gels without RGD, only 10 μM RGD was required to induce a 
significant increase in cyst size. In contrast, 50 μM or higher concentrations of RGD was 
required to induce a significant shift in lumen and apical polarity phenotypes versus gels 
without RGD. Between 100 μM and 250 μM RGD, major phenotypic conversions from 
no lumen to multiple lumen cysts and from external apical polarity to internal apical 
polarity were observed. LM basement membrane assembly in PEG-4MAL was also 
modulated by RGD concentration such that high density of RGD promoted formation of 
basement membranes resembling those in Coll I gels. Blockade of integrin binding using 
function-blocking antibodies confirmed that αvβ3 binding is sufficient to promote 
physiological polarization. Surprisingly, αvβ3 blockade had no impact on LM basement 
membrane assembly. Finally, β1 integrin binding was shown to be critical for both 
physiological polarization and LM basement membrane assembly. 
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Presentation of integrin binding ligands is one of the primary modes by which ECM 
modulates epithelial morphogenesis [28, 176]. Since Pierschbacher and Ruoslahti showed 
that the cell attachment activity of fibronectin (FN) could be duplicated with small 
fragments containing the RGD tripeptide, there has been tremendous interest in 
immobilizing oligopeptides in place of full-length proteins to confer bioactivity to 
biomaterials [177, 179]. Furthermore, the discovery of integrins and their amino acid 
binding motifs raised the appeal of peptides for targeting specific receptors to control 
specific cell responses [180]. Today, oligopeptides offer low cost, easy synthesis, high 
levels and control of ligand availability, high achievable signal density, and cell surface 
receptor selectivity.  
When integrins bind extracellular ligands, intracellular signals are initiated [181]. In 
cell cultures on planar substrates, the extent of integrin signaling can be directly 
controlled by the density of ligand presented on the substrate [182]. In the present study, 
we embedded MDCK II cells in 3D microenvironments that present specific densities of 
adhesive ligand. In the absence of RGD, cells grew into cysts with external apical 
polarity and no lumen. These cysts match those that occur when MDCK II cells are 
grown in suspension [183]. We hypothesized that, in the absence of RGD, lack of 
integrin-binding ligands in the extracellular space leaves the cells without an “outside” 
signal. Thus, the outside of the cyst is established as a free surface (legitimately, in 
suspension) and the apical membrane components are located there. The matching result 
demonstrates that the PEG-4MAL hydrogel can encapsulate epithelial cells while 
presenting a “blank slate” in terms of signaling and spatial cues. The high tethering 
efficiency of PEG-4MAL allowed us to investigate the dose-response of RGD density. 
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Incorporation of RGD at 10 μM concentration resulted in a significant increase in cyst 
size versus gels without RGD. The increase in cyst size most likely indicates increased 
proliferation, as the cysts in both conditions typically had no lumens (Figure 4.2b, c). 
Integrin binding to RGD has been shown to promote proliferation on engineered surfaces 
[110, 184]. At RGD concentrations up to 100 μM, cysts with external apical polarity were 
dominant. However, at 250 μM RGD, a major phenotypic shift was observed, as nearly 
all cysts had internal apical polarity. Although RGD is bound by a variety of integrins, in 
the absence of synergistic amino acid sequences found in full-length RGD-containing 
proteins, RGD is primarily a ligand for integrin αvβ3 [178]. In this study, blockade of 
αvβ3 binding resulted in inverted cyst polarity and confirmed that integrins sense the 
RGD ligand in PEG-4MAL to orient polarity in MDCK II cysts. Together these data 
suggest that a threshold of integrin signaling at the basal surface of the cyst is required for 
physiological orientation of polarity. 
When embedded in Coll I gels, MDCK II cells divide to form clonal clusters of 
several cells within two days. Then, during days 3-5, the beginnings of a hollow cavity, 
or lumen, is visible at the center of most clusters, even as cells at the periphery continue 
to divide. By day 10, a spherical monolayer of cells surrounds a single, fluid-filled lumen, 
typically [92, 156]. This process has been interrogated for decades, using integrin 
function-blocking antibodies, alternative natural ECMs including LM-rich Matrigel
TM
, 
and myriad loss-of-function and gain-of-function modifications affecting signaling 
molecules [27, 53, 54, 95, 96, 101]. Together, these studies have exposed a framework in 
which bi-directional signaling through β1 integrin, with activation of  the small GTPase 
Rac1, organizes secreted LM at the cyst-ECM interface to define an axis of polarity [53-
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55]. Then, lumen formation proceeds as cells lacking contact with ECM die via apoptosis 
[185]. 
How does the β1-Rac1-LM axis observed in MDCK cyst morphogenesis in collagen 
inform interpretation of MDCK II cyst morphogenesis in RGD-presenting PEG-4MAL 
hydrogels? Is the β1-Rac1-LM signaling axis active in PEG-4MAL hydrogels? 
It must first be acknowledged that there are several structural and biochemical 
differences between Coll I and a PEG-4MAL hydrogel. Whereas Coll I is a matrix of 
protein fibrils bound by non-covalent interactions, PEG-4MAL hydrogel is composed of 
covalently-crosslinked synthetic polymer chains in a regular meshwork. The resulting 
mesh size in the collagen gel is on the order of microns (~10.4 μm for 2.0 mg/mL gel 
[186]) whereas the PEG-4MAL hydrogel mesh size is estimated to be in the tens of 
nanometers [187]. Furthermore, owing to microns-long fibers and physical crosslinks in 
collagen gels, cellular tractions may extensively remodel the matrix microstructure. Both 
systems are sensitive to degradation by a broad range of matrix metalloproteinases 
(MMPs), as the PEG-4MAL hydrogel is crosslinked with a collagen derived MMP-
sensitive peptide. Finally, whereas cell attachment to collagen gels is primarily mediated 
by integrin α2β1, PEG-4MAL hydrogels in this study exclusively present the RGD 
peptide, a ligand primarily bound by integrin αVβ3. Although RGD sites are present in 
Coll I, they are typically hidden from integrin binding [67].  
In spite of these differences, mature cysts grown in PEG-4MAL with high RGD 
concentration resemble those grown in Coll I and follow a similar development pattern 
over 10 days (see Chapter III). In Coll I gels, cysts with external apical polarity result 
when β1 integrin binding is blocked using function-blocking antibody AIIB2 [53]. 
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However, the inversion of polarity involves more than missing spatial cues. First, 
blockade of β1 integrin binding results in decreased Rac1 activation and increased RhoA 
activation.  Then, the increased RhoA activity imposes its effects through ROCK I and 
myosin II activities. Forcing Rac1 activation with a constitutively active construct 
prevents the inversion of polarity [55]. It would be interesting to see whether inverted 
polarity in PEG-4MAL gels could be prevented by inhibition of RhoA effectors. 
Along with β1 integrin and Rac1, the third component of polarity orientation in 
collagen gels is LM secretion and assembly into the basement membrane. When β1 
integrin binding is blocked by AIIB2, or a dominant negative Rac1 is expressed in 
MDCK, inverted cyst polarity is accompanied by an incomplete LM basement 
membrane, although synthesis and secretion of laminin are normal [53-55]. Addition of 
exogenous laminin-111, which self assembles in vitro, partially restores internal apical 
polarity [54, 188]. In PEG-4MAL gels with high concentration of RGD, a thin layer of 
secreted LM is visible in at the periphery of 10-day-old cysts (Figure 4.3). Interestingly, 
blocking αVβ3 integrin binding caused external apical polarity but did not disrupt the LM 
basement membrane assembly. How can αVβ3 signaling be such a potent modulator of 
cyst polarity without discernibly influencing LM basement membrane assembly? This 
observation is consistent with a model in which polarity is stabilized early in cyst 
development such that LM basement membrane assembly proceeds later in culture 
without affecting polarity. In fact, Mostov and colleagues acknowledge that β1 function-
blocking antibody AIIB2 is ineffective in inverting cyst polarity when added after day 
three of culture in Coll I gels [55].  
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In contrast to the αVβ3 blocking experiment, blocking β1 integrin binding in PEG-
4MAL gels with RGD prevented physiological polarization and disrupted LM basement 
membrane assembly (Figure 4.4). The β1 integrin blocking result is consistent with the 
observations of Matlin and Mostov in MDCK 2D and 3D cultures, respectively [53, 99, 
103]. Importantly, these findings affirm a central role of β1 integrin signaling in MDCK 
II cyst morphogenesis in the context of a microenvironment that does not initially present 
β1 integrin-binding ligands. We presume that the cell-secreted LM basement membrane 




We have exploited a highly-efficient Michael-reactive PEG macromer to fabricate 
bioartificial hydrogels that incorporate cell adhesion ligands, permit cell-responsive 
degradation, and exhibit elastic properties resembling natural ECM extracts. In culturing 
MDCK II epithelial cells in these engineered PEG-4MAL matrices over a range of 
incorporated RGD concentration, we showed that cyst size, apical polarity, and lumen 
phenotypes are remarkably sensitive to adhesive ligand density. Thus, we conclude that a 
threshold level αVβ3 integrin signaling, via binding RGD, is required for establishment 
of internal apical polarity. Furthermore, our findings affirm a central role of β1 integrin 
signaling in orientation of polarity and assembly of LM basement matrix during cyst 
morphogenesis. 
 
Materials and Methods 
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Antibodies (and other reagents) 
The following primary monoclonal (mAb) and polyclonal (pAb) antibodies were used: 
Mouse anti-gp135/podocalyxin (supernatant 3F2 1D8, kind gift of G. Ojakian, SUNY 
Downstate), rabbit anti-laminin (LM) (Sigma-Aldrich, St. Louis, MO). Anti-LM antibody 
was raised against intact LM-111, consisting of α1-, β1-, and γ1-chains, and may also 
detect other LM isoforms consisting of those chains (e.g., LM-511) [53, 54]. Mouse anti-
αVβ3 integrin function blocking mAb (LM609, EMD Millipore, Billerica, MA), rat anti-
β1 integrin function blocking mAb (AIIB2, proclin-free developed by Caroline H. 
Damsky and obtained from the Developmental Studies Hybridoma Bank developed under 
the auspices of the NICHD and maintained by The University of Iowa, Department of 
Biology, Iowa City, IA 52242), rat IgG1 isotype control mAb (RTK2071, Biolegend, San 
Diego, CA), mouse IgG1 isotype control mAb (MOPC-21, Biolegend, San Diego, CA) . 
The following secondary antibodies were used: goat anti-mouse IgG Alexa Fluor 488, 
goat anti-rat IgG Alexa Fluor 555, goat anti-rabbit IgG Alexa Fluor 488, donkey anti-
rabbit IgG Dylight 649 (Thermo Fisher Scientific, Rockford, IL). Nuclei were stained 
with Hoechst 33342 and filamentous actin was stained with rhodamine phalloidin (Life 
Technologies). Synthetic adhesive peptides GRGDSPC, GRDGSPC, and crosslink 
peptide GCRDGPQGIWGQDRCG were obtained from aapptec, Louisville, KY. 
 
Cell culture 
Madin-Darby canine kidney (MDCK) strain II epithelial cells (ECACC via Sigma-
Aldrich) were maintained in Eagle’s minimal essential media (EMEM) (ATCC, 
Manassas, VA) supplemented with fetal bovine serum (Life Technologies) at 10% (v/v), 
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Penicillin (100 IU/mL, Life Technologies) and streptomycin (100 μg/mL, Invitrogen) and 
fungizone (Invitrogen). 
 
Three-dimensional cell culture in PEG-maleimide hydrogels 
For 5.0% (w/v) hydrogels, four-arm PEG-maleimide (PEG-4MAL) (MW = 22000, 
Laysan Bio, Arab, AL) was dissolved in diH20 at 12.5% (w/v) and desalted using a 7 
kDa MW cutoff column (Zeba, Thermo Fisher Scientific, Waltham, MA). After 
lyophilization, desalted PEG-4MAL was dissolved in a triethanolamine (TEA) (Sigma-
Aldrich) buffer (4 mM in DPBS, pH 7.4) to form a 12.5% solution (w/v) (2.5x times that 
of the final 5% hydrogel). Dilutions for lower wt% gels were made at this step. Adhesive 
peptide (GRGDSPC) or non-adhesive peptide (GRDGSPC) or combination was 
dissolved in TEA (to form 10 mM peptide solution). Two volumes of PEG-4MAL 
precursor solution was mixed with one volume of peptide solution. The mixture was 
incubated at room temperature for at least 10 minutes to achieve functionalized PEG-
4MAL precursor. Rapidly-degrading bis-cysteine crosslinking peptide 
(GCRDGPQG↓IWGQDRCG) (“GPQ”) (↓denotes enzymatic cleavage site) was 
dissolved in TEA at concentration that achieves 1:1 maleimide:cysteine ratio after 
accounting for maleimide groups reacted with adhesive peptide. Actively growing 
MDCK cells were trypsinized, counted and resuspended at 5x final cell density in ice-
cold serum-free EMEM and stored on ice. 12-well silicone isolator sheets (4.5 mm 
diameter well, 1 mm thick, Grace Bio-Labs, Bend, OR) were pressed onto microscope 
slides and exposed glass was treated with Sigmacote (Sigma-Aldrich). To form 20 μL 
gels, 4 uL of crosslinker solution was pipetted into each well. Then, 4 uL of cell 
suspension was mixed with 12 μL of functionalized PEG-4MAL precursor solution. 16 
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μL PEG-cell mixture was then pipetted into well and mixed 10-15 times. Gelation was 
apparent within 30 seconds. Gels were moved to 37C, 5% CO2 humidified incubator for 
20-25 minutes to facilitate crosslinking. Gels were then swelled in complete growth 
media and moved to 48-well plate with 0.5 mL complete growth media per well. For 
studies with integrin function-blocking antibodies, cells were pre-incubated (30 min, 
rocking, room temp) in 0.1% bovine serum albumin in serum free EMEM containing 
antibodies. AIIB2 (anti-β1) was used at 8 μg/mL, LM609 (anti- αVβ3) and isotype 
controls were used at 10 μg/mL. 
 
Three-dimensional cell culture in type I collagen gels 
To prepare a 2 mg/mL neutral type 1 collagen solution, eight parts type I collagen from 
bovine tendon (3 mg/ mL, Sigma-Aldrich) was mixed with one part 10X DMEM on ice 
(see below) and the pH adjusted to 7.2 – 7.6 using 0.1M NaOH. A cell suspension in 
serum-free media was added to the mixture to dilute the solution to 2 mg/mL type I 
collagen and result in 40,000 cells/mL. 150 uL of the cell-collagen mixture was added to 
the wells of an 8-well chambered coverglass. Collagen gel was allowed to solidify for 30 
– 45 minutes in a 37C air incubator. 200 μL complete media added to each well. 
Alternatively, 75 uL of the cell-collagen mixture was pipetted onto a 6.5 mm polyester 
permeable support (0.4 μm pore, Corning, Corning, NY) in a 24-well plate. 700 uL 
complete media was added to the bottom reservoir and 200 uL was added to the top 
reservoir after gel solidified.  
 
Immunofluorescence labeling of cysts 
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Gels were washed extensively in PBS+ (3x quickly and 2x 5 minutes) to remove media 
and fixed in 4% formaldehyde in PBS+ for 15 minutes while rocking at room 
temperature. After extensive washing in PBS+, gels were incubated 30 minutes in 
blocking buffer (1% bovine serum albumin, 1% goat serum, 0.1% fish skin gelatin, 0.5% 
Triton X-100, 0.05% sodium azide in PBS). Meanwhile primary antibodies were diluted 
in blocking buffer. Mouse anti-gp135 supernatant was used at 1:10 – 1:100 dilution and 
all others were used at 1:100. In a 48-well plate or 8-well chambered coverglass, 200 μL 
of primary antibody solution was added to each PEG-4MAL gel and PBS+ added to 
empty wells for humidity. Plates were sealed with parafilm and placed on orbital shaker 
at 4C overnight. After extensive washing in blocking buffer, secondary antibodies and 
nuclear stain were diluted in blocking buffer and added to gels. All fluorescently-labeled 
secondary antibodies were used at 1:200 dilution, rhodamine phalloidin at 1:50, and 
DAPI nuclear stain was used at 1:1000 dilution. Secondary antibody incubation 
proceeded overnight as described for primary antibody. After further washing in blocking 
buffer, gels were washed in PBS+ and post-fixed for 15 minutes in 4% paraformaldehyde 
in PBS+. Gels were again washed in PBS+ and stored in PBS+ with sodium azide at 4C 
protected from light. To label extracellular laminin, the appropriate primary antibody was 
added to the culture media at 1:50 for four hours prior to fixation. 
 
Cyst collection in agarose gel for imaging 
Following immunofluorescence labeling, each gel was placed in well of 8-well 
chambered coverglass (1.0 thickness, Thermo Fisher Scientific) and 250 μL of 0.1% 
collagenase I (250 U/mL, Worthington Biochemical) in 2% low-melt agarose (Lonza, 
Walkersville, MD) in PBS. After several hours incubation (shaking?) at 37C, cysts were 
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Phase contrast images were captured daily during the course of three-dimensional 
cultures using an inverted microscope (Nikon) and SPOT imaging software (Diagnostic 
Instruments, Sterling Heights, MI). Fluorescent images for cyst scoring were captured 
using a C1 or C2 laser scanning confocal microscope with a 20x  or 60x objective and 
EZ-C1 or NIS Elements software (Nikon, Melville, NY). Each field contained up to 
dozens of cysts. A single z-slice was captured at an appropriate plane. Each image was 
captured as the merge of four separate channels corresponding to blue, green, red, and 
transmitted light, respectively. 
 
Quantitation of cyst morphology 
For multiplicity of lumens: a cyst cross-section having a single hollow space and outlined 
by a monolayer of cells was designated as having a single lumen, a cyst cross-section 
having a single hollow space bounded by multiple layers or groups of cells was 
designated as having a partial lumen, a cyst cross-section having multiple hollow spaces 
was designated as having multiple lumens, and a cyst cross-section having no hollow 
spaces was designated as having no lumen. 
For polarity: a cyst cross-section in which the interior of lumens are lined with gp135 and 
the exterior of cyst lacks gp135 possessed interior apical polarity, a cyst cross-section in 
which the interior of lumens lack gp135 and the exterior of cyst is lined with gp135 
possessed exterior apical polarity, a cyst cross-section in which the interior of lumen and 
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the exterior of cysts showed similar accumulation of gp135 possessed mixed apical 
polarity. Cyst size was measured from fluorescent images of cyst cross sections. 
Minimum and maximum feret diameters were measured for each cysts using ImageJ and 
the average was reported. See ([174]). 
 
Statistical Analysis 
For continuous variable data, we used one-way ANOVA with Tukey’s tests for multiple 
comparisons, where necessary. For categorical data, we implemented a chi-squared test 
with Bonferroni’s test for multiple comparisons, where necessary (See [175]). GraphPad 
Prism software (GraphPad, La Jolla, CA) was used to implement analyses.  
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 How the 3D multicellular tissue structures that comprise the functional units of 
organs including the kidney, lung, and breast, are formed, maintained and repaired is a 
topic of intense research. Interest is driven by the implications of epithelial tissue 
assembly and homeostasis for cancer progression and prospective regenerative therapies. 
The studies described in this thesis manipulated physical and biochemical aspects of the 
microenvironment in which epithelial morphogenesis occurs. 3D cell cultures in natural 
ECM extracts, including type I collagen (Coll I), have enabled observation of epithelial 
morphogenesis, a hard-wired, multicellular differentiation program that integrates cell-
ECM adhesion, cell proliferation, and ECM remodeling to achieve functionally 
differentiated structures like hollow cysts and tubules [154]. Nevertheless, critical 
limitations of natural ECM extracts, including clinical incompatibility, lot-to-lot 
variability and undefined presentation of cell adhesion motifs motivated development of 
engineered ECM mimics for detailed studies. PEG-based hydrogels offer tunable, tissue-
like elastic properties, modular incorporation of cell adhesion peptides and cell-
responsive degradation, and an excellent record in the clinic. Therefore, chapter III 
demonstrated culture of MDCK II epithelial cells in cell-adhesive PEG hydrogels with 
tunable elastic properties, crosslink density, and degradability. The influence of matrix 
physical and biochemical properties on MDCK II cyst morphogenesis was quantitatively 
evaluated using this system. 
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Currently, there is great interest in understanding how the mechanics of the 
microenvironment influence tissue homeostasis, particularly in the cases of epithelial 
organs where cancer progression has been associated with tissue stiffening [166]. 
Therefore, the linear relationship between elastic modulus and polymer wt% observed in 
PEG-4MAL hydrogels, within the sub-kPa range, presents an attractive opportunity to 
investigate the influence of matrix mechanics on epithelial morphogenesis. 
Presentation of integrin binding ligands is one of the primary modes by which 
ECM modulates epithelial morphogenesis [28, 176]. Elucidation of the amino acid 
binding motifs bound by particular integrins allows use of  oligopeptides for targeting 
specific receptors to control specific cell responses [180]. Furthermore, oligopeptides 
offer low cost, easy synthesis, high levels and control of ligand availability, high 
achievable signal density, and cell surface receptor selectivity. 
In this thesis, we hypothesized that the polymer wt% of a synthetic matrix and the 
concentration of adhesive peptides presented therein would modulate MDCK II cell 
proliferation and cyst morphogenesis. Cell proliferation within PEG-4MAL hydrogels 
was assayed using an antibody-free, fluorescently-detected thymidine analogue, while 
cyst size, apico-basal polarity, lumen formation and basement membrane assembly were 
quantified following confocal immunofluorescence imaging. 
 
Polymer weight percentage influences cyst morphogenesis through effects on elastic 
modulus, crosslink density and gel degradability 
 It is well established that most healthy cells maintain a “tensional homeostasis” by 
generating cytoskeletal tension in response to stresses exerted by the microenvironment 
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[166, 167]. Even in what are considered static tissues, cells are subject to hydrostatic 
pressure and respond to changes in matrix mechanics. In the mammary gland, for 
instance, the bi-layered epithelium lining the ducts and alveoli is subject to outward 
pressure during milk production. These cells respond with contractility that forces milk 
out of the alveoli and into the larger ducts toward the nipple [166]. Mammary tumors are 
often detected as stiffened regions of otherwise soft tissue. Furthermore, tumor stiffness 
may ultimately be correlated with increased morbidity in human breast cancer [167]. On 
the tissue level, mammary epithelial cells (MECs) respond to stiffening of their 
microenvironment with increased stiffness of the cellular cortex. In tumors, this results in 
enhanced ability to migrate through dense basement membranes and to metastasize to 
distant sites. In vitro, immortalized human MECs cultured in soft ECM extracts like Coll 
I or reconstituted basement membranes like Matrigel
TM
 form polarized spherical acini 
that resemble alveolar end buds. However, when the microenvironment is progressively 
stiffened, the small, spherical, polarized acini give way to larger structures with 
destabilized cell-cell junctions, perturbed polarity, disrupted lumen formation, and 
elevated extracellular signal-regulated kinase (ERK) signaling [111]. 
In PEG-4MAL hydrogels, the elastic modulus of the matrix varies linearly with 
polymer wt% over the range 4.0% – 10% (w/v) (400 – 1500 Pa) [1]. In chapter III, we 
sought to determine how elastic properties of the PEG-4MAL matrix influenced MDCK 
II cell proliferation and cyst morphogenesis. We found that the cell growth-permissive 
range of the PEG-4MAL matrix with these cells was limited to 3.5% - 4.5%. 
Nevertheless, we observed dramatic differences in apico-basal polarity and lumen 
phenotypes as wt% was varied. As will be discussed later, we concluded that the 
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differences in cyst phenotypes are best attributed to shifts in elastic modulus and 
crosslink density that accompany wt% changes and potentially affect the adhesive 
signaling and degradability of the hydrogel, respectively 
 Future studies can potentially overcome the limited set of PEG-4MAL molecular 
weight and wt% configurations that permit MDCK II proliferation and therefore access a 
wider range of elastic moduli. To do this, immature MDCK II clusters or mature cysts 
may be generated growth-permissive PEG-4MAL gels and then collected and re-
embedded in gels that do not permit proliferation of single cells. PEG-4MAL hydrogels 
are rapidly dissolved in collagenase solutions without compromising cell viability. 
Subsequent washing and gentle pelleting may produce a cluster or cyst suspension that 
may be readily re-embedded in new gels. As immature cell clusters in PEG-4MAL 
typically have external (inverted) apical polarity (data not shown), inversion of polarity 
during transplantation would not be a significant concern. In the case of mature cysts 
with assembled basement membranes, it will be important to determine whether polarity 
and basement membrane integrity could be maintained during transplantation. 
 Several groups have shown that degradability is critical parameter for modulating 
cell behaviors in synthetic matrices [130, 138, 141, 168]. In the PEG-4MAL system, as 
used in this thesis, variations in polymer wt% cause dramatic changes in crosslink 
density. Thus, increases in PEG-4MAL wt% increased crosslink density and, as a result, 
encapsulated cells were presented with an increasingly difficult burden of local 
degradation in order to divide. Directly modulating matrix degradability with slow-
degrading crosslink peptides or with soluble MMP inhibitors at an otherwise growth-
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permissive PEG-4MAL wt% provided further evidence that rapid local degradation is 
required for cyst development. 
 PEG-4MAL wt% also influences hydrogel swelling. This indicates an effect on 
the mesh size of the hydrogel network. For 4.0% gels, we estimate a theoretical mesh size 
of ~35 nm, nearly three orders of magnitude smaller than that of Coll I gels. Lower 
molecular weight PEG-4MAL would have even smaller mesh size. Thus, there is reason 
to believe that high wt% PEG-4MAL may inhibit nutrient diffusion. Ongoing studies will 
assay bulk gel degradation and estimate diffusion coefficients. 
 
Threshold of RGD density, is required for establishment of internal apical polarity 
Since Pierschbacher and Ruoslahti showed that the cell attachment activity of 
fibronectin (FN) could be duplicated with small fragments containing the RGD tripeptide, 
there has been tremendous interest in immobilizing oligopeptides in place of full-length 
proteins to confer bioactivity to biomaterials [177, 179]. The robust Michael-type 
addition reaction between maleimide and thiols allows incorporation of precise quantities 
of cysteine-containing peptides in PEG-4MAL hydrogels. In this thesis, precision 
functionalization allowed us to show that increments of RGD concentration as small as 
10 μM modulate cyst size. Titrating RGD concentration from 0 – 2000 μM indicated that 
a threshold level of integrin binding is required for physiological orientation of apico-
basal polarity. Function-blocking antibody incubation suggested that signaling through 
αVβ3 integrin specifically mediated polarization. Further antibody blocking showed that 
β1 integrin signaling was also required polarization and LM basement membrane 
assembly. Together, these findings suggest that the β1 integrin –LM signaling axis 
93 
established in Coll I gels is an appropriate paradigm for interpreting cyst morphogenesis 
results in PEG-4MAL. 
Nevertheless, future studies will adapt protocols to evaluate intracellular signaling 
involving Rho GTPases within PEG-4MAL. In 2D systems, threshold levels of ECM 
ligand binding cause integrin receptor clustering and formation of focal adhesion 
complexes [182]. These complexes subsequently act as signaling hubs as factors like 
focal adhesion kinase (FAK) and others are recruited. Ultimately, focal adhesions are 
linked to the cytoskeleton and allow the cell to exert significant forces across the 
membrane onto the ECM. Thus, in future work, it will be important to determine whether 
RGD binding by αVβ3 initiates assembly of focal adhesions and integrin signaling. 
Our findings in this thesis have reinforced the notion that, during cyst 
morphogenesis, MDCK II cells bind extracellular LM using β1 integrin to orient an axis 
of polarity. We made these observations using RGD peptides to provide an initial integrin 
binding signal that apparently stimulated LM secretion and eventual β1 integrin binding. 
However, in LM-rich basement membranes extracts like Matrigel
TM
, a pre-assembled LM 
basement membrane promotes rapid MDCK II cyst polarization and lumen formation (at 
the two-cell stage) without cell death [123]. Furthermore, addition of soluble LM-111 or 
basement membrane extract to cultures of MDCK II in non-ideal microenvironments 
results in enhanced cyst polarization and lumen formation [53, 55, 154]. It is known that 
particular LM isoforms are involved in specific cell behaviors [189]. For instance, 
following kidney tubule injury, denuded tubules are repopulated by neighboring cells that 
secrete and migrate on LM-332 to fill holes in the epithelial monolayer [31, 52, 190]. 
However, LM-332 is also implicated in elevated cell adhesion and migration in 
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polycystic kidney disease [61, 191]. Over the last decade, Nomizu and colleagues have 
developed high-throughput screening techniques to identify bioactive peptides from LM-
111, LM-511, and LM-332 [192-196]. As the hydrogel-forming Michael-type addition 
reaction used here can incorporate essentially any peptide that contains a free cysteine, 
we are interested in using the PEG-4MAL system to investigate the influence of specific 
LM peptide domains on cyst morphogenesis. 
 
Future Directions 
Investigating interplay between cell-ECM forces and cyst morphogenesis 
In spite of limitations in the current study, PEG-4MAL hydrogels are uniquely 
suited to study of matrix mechanical effects in MDCK II cyst morphogenesis. In fact, we 
have exploited the excellent optical transparency and water-like refractive properties of 
PEG-4MAL to measure cyst-generated tractions. We encapsulated MDCK II cells along 
with 200 nm fluorescent beads in PEG-4MAL gels and observed bead displacements with 
live cell imaging. When a two-day-old MDCK II cyst, not yet having a lumen, was 
ablated with sodium azide, we observed a dramatic positive displacement of surrounding 
beads, indicating that the living cyst had contracted the gel locally (Figure 5.1a). 
Interestingly, we observed that larger cysts with lumens collapsed upon ablation, 
suggesting that mature cysts exert pressure on the surrounding matrix (data not shown). 
To calculate traction forces, we modeled the system as an infinite elastic solid with a 







u   
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where u is matrix displacement (meters), P is pressure (Pa), E is elastic modulus (Pa), a is 
cyst radius (meters), and r is distance from center of cyst (meters) [197]. We measured 
bead displacements (to visualize matrix displacement) using ImageJ Mosaic plugin [198] 
and employed a least-squares fit with E = 500 Pa (for 4.0% PEG-4MAL hydrogel) and 
cyst radius of 17 μm to calculate a pressure or, in this case, a traction force of 273 Pa 
(Figure 5.1). This calculated force is in excellent agreement with those calculated by 
others for multicellular epithelial tissues (150 Pa for rapidly-proliferating lung carcinoma 
spheroids) and appropriately smaller than those calculated for wound-closing fibroblasts 
(1700 Pa, NIH 3T3) [199]. Notably, the spherical symmetry of the cyst dramatically 




Figure 5.1. Fluorescent particle tracking in PEG-4MAL hydrogel reveals mechanical 
behavior of multicellular cysts. Live cell imaging of solid cyst (a) revealed expansion of 
cyst perimeter after destruction with sodium azide (b). c, Arrows indicate displacement of 
beads due to cyst contractility prior to sodium azide treatment. d, Least squares fit of 
bead displacement versus initial distance from cyst. Scale bars 10 μm.  
 
 Given these promising preliminary results, future work will investigate the 
influences of integrin binding, matrix elastic properties, and cellular contractile 
machinery on cyst tractions. First, to investigate the evolution of forces exerted upon the 
ECM during cyst development from single cells to mature structures, cells embedded 
within cyst growth-permissive PEG-4MAL hydrogels, will be ablated with SDS at 
various time points. We expect that the magnitude of cellular tractions will decrease from 
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a maximum in small, solid clusters to a minimum when lumen formation is complete. In 
mature cysts with single lumen, we expect that polarized fluid transport into the lumen 
will result in a positive pressure on the matrix. It will also be interesting to see how the 
existence of partial or multiple lumens influence cyst tractions. Next, to determine how 
cell-ECM adhesion modulates cyst generated forces, we will culture MDCK II cells in 
PEG-4MAL matrices presenting a range of RGD concentrations. By controlling the 
number of integrin-ligand bonds, we expect that cyst tractions will scale with RGD 
concentration and provide further illustrate the influence of integrin-signaling in MDCK 
cyst morphogenesis. Recent studies with MDCK II in Coll I gels have shown that 
extracellular LM, signaling through β1 integrin, reduces RhoA activation and its 
downstream affects through ROCK I and myosin II [55]. In this thesis, we showed that 
the PEG-4MAL system with RGD promotes robust proliferation without β1 integrin 
ligand presentation but nevertheless relies on β1 signaling, likely through binding LM, to 
enable apico-basal cyst polarity. Therefore, it will be interesting to see whether the 
inverted apico-basal polarity that we observed upon β1 integrin blockade is associated 
with elevated contractility. In an orthogonal approach, these experiments could employ 
PEG-4MAL matrices engineered to present active LM-derived peptides to directly, and 
perhaps dose-dependently, regulate RhoA activation and cell-exerted matrix contraction. 
This proposed work is potentially transformative in that it will yield multicellular 
tissue traction profiles in three-dimensions enabled by rationally-designed biomimetic 
materials that feature precise tuning of the mechanics and biochemical properties of the 
microenvironment. 
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Other very recent contributions have employed highly-specialized equipment and 
analytical techniques to study single cell mechanobiology within synthetic matrices or 
cell sheet mechanics upon 2D materials. However, this proposal enables mechano-
biological characterization of actively developing 3D tissue rudiments in a medium where 
cell-matrix interactions, elastic properties, and structural evolution (degradation and 
ECM deposition) may be precisely tuned or monitored. This system yields multicellular 
traction force profiles arising from a vast space of tissue morphogenetic phases and 
microenvironmental configurations that provide insights into developmental processes 
and disease states. 
 
Modulating epithelial polarity with dynamic microenvironments  
An emerging strategy for investigating cell responses to changes in the 
microenvironment involves dynamic ligand presentation. One approach employs 
engineered adhesive peptides whose integrin binding domains are concealed by light-
sensitive “cage” molecules. Upon irradiation with specific wavelengths of light, the cage 
is removed and the adhesive motif is exposed. García and del Campo have pioneered use 
of these caged-RGD reagents to dynamically regulate cell adhesion, migration, and 
differentiation on surfaces [200, 201]. In this thesis, we observed that MDCK II cells 
grown in PEG-4MAL gels presenting low (< 250 μM) concentration of RGD grew into 
clusters without lumens with inverted apical polarity over 10 days. Several studies have 
established that pools of integrins are expressed on the apical surfaces of epithelia, with 
implications for polarity reversal upon exposure to the appropriate ECM ligands [24, 101, 
103]. Thus, it would be interesting to see whether delayed exposure of caged-RGD in a 
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PEG-4MAL matrix would rectify inverted apico-basal polarity. Future work could also 
make use of built-in fluorescence recovery after photobleaching (FRAP) modules on 
confocal microscopes to locally expose cell adhesion ligands and explore how regional 
differences in integrin binding influence cyst polarity. 
 
Conclusions 
Epithelial morphogenesis is a hard-wired, multicellular differentiation program 
that dynamically integrates microenvironmental cues to coordinate cell fate processes 
including adhesion, migration, proliferation, and polarization. Thus, epithelial 
morphogenesis is an instructive mode of tissue assembly, maintenance, and repair. 
Recently, limitations of natural ECM extracts have motivated development of a synthetic 
ECM platform for detailed studies. In this thesis, PEG-4MAL was covalently 
functionalized with adhesive peptides and crosslinked with proteolytically-cleavable 
structural peptides in the presence of epithelial cells. The highly-efficient Michael-
addition reaction enabled fabrication of hydrogel with elastic properties resembling 
natural ECMs [1]. By culturing MDCK II epithelial cells in these engineered PEG-4MAL 
matrices over a range of polymer wt% and RGD peptide concentration, we showed that 
the biochemical and physical properties of the matrix, particularly integrin signaling via 
ligand binding, elastic modulus, and matrix degradability, effectively modulate 
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